Advertisements


Trump calls New York criminal probe a "witch hunt" and claims a poll shows he is the frontrunner in 2024

"... Our prosecutors are politicized, and I will just have to keep on fighting like I have been for the last five years!" Trump said. Donald Trump addresses the Conservative Political Action Conference (CPAC) held in the Hyatt Rege.....»»

Category: dealsSource: nytMay 26th, 2021

Donald Trump could be charged with multiple crimes over his attempts to overturn his loss in the state of Georgia, report says

The Brookings Institution report says Trump and his allies attempted to pressure Georgia officials to "change the lawful outcome of the election." Former President Donald Trump. Michael M. Santiago/Getty Images Donald Trump could be charged with crimes over Georgia election interference, a new report says. The report says Trump and his allies pressured Georgia officials to overturn his loss in the state. Trump is facing several probes in relation to his post-election conduct in Georgia. See more stories on Insider's business page. Former President Donald Trump could be charged with multiple crimes over election interference in Georgia, a new report says.The report by the Brookings Institution, a leading think tank in Washington DC, analyzes publicly available evidence that shows that Trump and his allies attempted to pressure Georgia officials to "change the lawful outcome of the election."A key piece of evidence is the now-infamous call made by Trump on January 3 to Georgia's Republican Secretary of State, Brad Raffensperger. He told him to "find 11,780 votes" to overturn Biden's win.The report adds that Trump publicly pressured and personally contacted several other officials in Georgia to ask them to help him overturn his loss in the state.It includes Governor Brian Kemp and Attorney General Chris Carr, who Trump reportedly placed direct calls to in December to urge them to go along with "his increasingly desperate plans to decertify his loss.""We conclude that Trump's post-election conduct in Georgia leaves him at substantial risk of possible state charges predicated on multiple crimes," the report said."These charges potentially include criminal solicitation to commit election fraud; intentional interference with performance of election duties; conspiracy to commit election fraud; criminal solicitation; and state RICO violations."The report added that criminal liability could extend to some Trump allies, including his personal lawyer Rudy Giuliani.Giuliani appeared before committees in the Georgia Capitol with the intent of convincing state lawmakers to "take extraordinary action to reverse Biden's win," the report notes.In February, Raffensperger's office opened a probe into Trump's efforts to overturn his loss in the state.Fulton County District Attorney Fani Willis also launched a criminal investigation into Trump's conduct relating to the election.The Brookings Institution report analyzes these probes and suggests what crimes Trump could be charged with and his legal defenses.The report suggests that Trump would likely claim immunity, arguing he cannot be prosecuted for actions taken while he was president.Former presidents enjoy a measure of immunity for actions taken that "fall within the scope of their lawful duties as a federal official," according to the report. However, in this case, Trump's actions were "well outside the scope of his official duties," the report says.Trump and his allies have continued to promote baseless claims that the 2020 election was fraudulent.The former president is currently facing several criminal probes over his conduct while in office, as well as his personal finances.Read the original article on Business Insider.....»»

Category: dealsSource: nyt21 hr. 3 min. ago

Futures Rise On Taper, Evergrande Optimism

Futures Rise On Taper, Evergrande Optimism US index futures jumped overnight even as the Fed confirmed that a November tapering was now guaranteed and would be completed by mid-2022 with one rate hike now on deck, while maintaining the possibility to extend stimulus if necessitated by the economy. Sentiment got an additional boost from a strong showing of Evergrande stock - which closed up 17% - during the Chinese session, which peaked just after Bloomberg reported that China told Evergrande to avoid a near-term dollar bond default and which suggested that the "government wants to avoid an imminent collapse of the developer" however that quickly reversed when the WSJ reported, just one hour later, that China was making preparations for Evergrande's demise, and although that hammered stocks, the report explicitly noted that a worst-case scenario for Evergrande would mean a partial or full nationalization as "local-level government agencies and state-owned enterprises have been instructed to step in only at the last minute should Evergrande fail to manage its affairs in an orderly fashion." In other words, both reports are bullish: either foreign creditors are made whole (no default) as per BBG or the situation deteriorates and Evergrande is nationalized ("SOEs step in") as per WSJ. According to Bloomberg, confidence is building that markets can ride out a pullback in Fed stimulus, unlike 2013 when the taper tantrum triggered large losses in bonds and equities. "Investors are betting that the economic and profit recovery will be strong enough to outweigh a reduction in asset purchases, while ultra-low rates will continue to support riskier assets even as concerns linger about contagion from China’s real-estate woes." That's one view: the other is that the Fed has so broken the market's discounting ability we won't know just how bad tapering will get until it actually begins. “The Fed has got to be pleased that their communication on the longer way to tapering has avoided the dreaded fear of the tantrum,” Jeffrey Rosenberg, senior portfolio manager for systematic fixed income at BlackRock Inc., said on Bloomberg Television. “This is a very good outcome for the Fed in terms of signaling their intent to give the market information well ahead of the tapering decision.” Then there is the question of Evergrande: “With regards to Evergrande, all those people who are waiting for a Lehman moment in China will probably have to wait another turn,” said Ken Peng, an investment strategist at Citi Private Bank Asia Pacific. “So I wouldn’t treat this as completely bad, but there are definitely a lot of risks on the horizon.” In any case, today's action is a continuation of the best day in two months for both the Dow and the S&P which staged a strong recovery from two-month lows hit earlier in the week, and as of 745am ET, S&P 500 E-minis were up 25.25 points, or 0.6%, Dow E-minis were up 202 points, or 0.59%, while Nasdaq 100 E-minis were up 92.0 points, or 0.60%. In the premarket, electric vehicle startup Lucid Group rose 3.1% in U.S. premarket trading. PAVmed (PVM US) jumps 11% after its Lucid Diagnostics unit announced plans to list on the Global Market of the Nasdaq Stock Market.  Here are some of the biggest movers today: U.S.-listed Chinese stocks rise in premarket trading as fears of contagion from China Evergrande Group’s debt crisis ease. Blackberry (BB US) shares rise 8.7% in premarket after co.’s 2Q adjusted revenue beat the average of analysts’ estimates Eargo (EAR US) falls 57% in Thursday premarket after the hearing aid company revealed it was the target of a Justice Department criminal probe and withdrew its forecasts for the year Amplitude Healthcare Acquisition (AMHC US) doubled in U.S. premarket trading after the SPAC’s shareholders approved the previously announced business combination with Jasper Therapeutics Steelcase (SCS US) fell 4.8% Wednesday postmarket after the office products company reported revenue for the second quarter that missed the average analyst estimate Vertex Energy Inc. (VTNR US) gained 2.1% premarket after saying the planned acquisition of a refinery in Mobile, Alabama from Royal DutVTNR US Equitych Shell Plc is on schedule Synlogic (SYBX US) shares declined 9.7% premarket after it launched a stock offering launched without disclosing a size HB Fuller (FUL US) climbed 2.7% in postmarket trading after third quarter sales beat even the highest analyst estimate Europe's Stoxx 600 index rose 0.9%, lifted by carmakers, tech stocks and utilities, which helped it recover losses sparked earlier in the week by concerns about Evergrande and China’s crackdown on its property sector. The gauge held its gain after surveys of purchasing managers showed business activity in the euro area lost momentum and slowed broadly in September after demand peaked over the summer and supply-chain bottlenecks hurt services and manufacturers. Euro Area Composite PMI (September, Flash): 56.1, consensus 58.5, last 59.0. Euro Area Manufacturing PMI (September, Flash): 58.7, consensus 60.3, last 61.4. Euro Area Services PMI (September, Flash): 56.3, consensus 58.5, last 59.0. Germany Composite PMI (September, Flash): 55.3, consensus 59.2, last 60.0. France Composite PMI (September, Flash): 55.1, consensus 55.7, last 55.9. UK Composite PMI (September, Flash): 54.1, consensus 54.6, last 54.8. Commenting on Europe's PMIs, Goldman said that the Euro area composite PMI declined by 2.9pt to 56.1 in September, well below consensus expectations. The softening was broad-based across countries but primarily led by Germany. The peripheral composite flash PMI also weakened significantly in September but remain very high by historical standards (-2.4pt to 57.5). Across sectors, the September composite decline was also broad-based, with manufacturing output softening (-3.3pt to 55.6) to a similar extent as services (-2.7pt to 56.3). Supply-side issues and upward cost and price pressures continued to be widely reported. Expectations of future output growth declined by less than spot output on the back of delta variant worries and supply issues, remaining far above historically average levels. Earlier in the session, Asian stocks rose for the first time in four sessions, as Hong Kong helped lead a rally on hopes that troubled property firm China Evergrande Group will make progress on debt repayment. The MSCI Asia Pacific Index climbed as much as 0.5%, with Tencent and Meituan providing the biggest boosts. The Hang Seng jumped as much as 2.5%, led by real estate stocks as Evergrande surged more than 30%. Hong Kong shares later pared their gains. Asian markets were also cheered by gains in U.S. stocks overnight even as the Federal Reserve said it may begin scaling back stimulus this year. A $17 billion net liquidity injection from the People’s Bank of China also provided a lift, while the Fed and Bank of Japan downplayed Evergrande risks in comments accompanying policy decisions Wednesday. Evergrande’s stock closed 18% higher in Hong Kong, in a delayed reaction to news a unit of the developer had negotiated interest payments on yuan notes. A coupon payment on its 2022 dollar bond is due on Thursday “Investors are perhaps reassessing the tail risk of a disorderly fallout from Evergrande’s credit issues,” said Chetan Seth, a strategist at Nomura. “However, I am not sure if the fundamental issue around its sustainable deleveraging has been addressed. I suspect markets will likely remain quite volatile until we have some definite direction from authorities on the eventual resolution of Evergrande’s debt problems.” Stocks rose in most markets, with Australia, Taiwan, Singapore and India also among the day’s big winners. South Korea’s benchmark was the lone decliner, while Japan was closed for a holiday In rates, Treasuries were off session lows, with the 10Y trading a 1.34%, but remained under pressure in early U.S. session led by intermediate sectors, where 5Y yield touched highest since July 2. Wednesday’s dramatic yield-curve flattening move unleashed by Fed communications continued, compressing 5s30s spread to 93.8bp, lowest since May 2020. UK 10-year yield climbed 3.4bp to session high 0.833% following BOE rate decision (7-2 vote to keep bond-buying target unchanged); bunds outperformed slightly. Peripheral spreads tighten with long-end Italy outperforming. In FX, the Bloomberg Dollar Spot Index reversed an earlier gain and dropped 0.3% as the dollar weakened against all of its Group-of-10 peers apart from the yen amid a more positive sentiment. CAD, NOK and SEK are the strongest performers in G-10, JPY the laggard.  The euro and the pound briefly pared gains after weaker-than-forecast German and British PMIs. The pound rebounded from an eight-month low amid a return of global risk appetite as investors assessed whether the Bank of England will follow the Federal Reserve’s hawkish tone later Thursday. The yield differential between 10-year German and Italian debt narrowed to its tightest since April. Norway’s krone advanced after Norges Bank raised its policy rate in line with expectations and signaled a faster pace of tightening over the coming years. The franc whipsawed as the Swiss National Bank kept its policy rate and deposit rate at record lows, as expected, and reiterated its pledge to wage currency market interventions. The yen fell as a unit of China Evergrande said it had reached an agreement with bond holders over an interest payment, reducing demand for haven assets. Turkey’s lira slumped toa record low against the dollar after the central bank unexpectedly cut interest rates. In commodities, crude futures drifted lower after a rangebound Asia session. WTI was 0.25% lower, trading near $72; Brent dips into the red, so far holding above $76. Spot gold adds $3.5, gentle reversing Asia’s losses to trade near $1,771/oz. Base metals are well bid with LME aluminum leading gains. Bitcoin steadied just below $44,000. Looking at the day ahead, we get the weekly initial jobless claims, the Chicago Fed’s national activity index for August, and the Kansas City fed’s manufacturing activity index for September. From central banks, there’ll be a monetary policy decision from the Bank of England, while the ECB will be publishing their Economic Bulletin and the ECB’s Elderson will also speak. From emerging markets, there’ll also be monetary policy decisions from the Central Bank of Turkey and the South African Reserve Bank. Finally in Germany, there’s an election debate with the lead candidates from the Bundestag parties. Market Snapshot S&P 500 futures up 0.7% to 4,413.75 STOXX Europe 600 up 1.1% to 468.32 MXAP up 0.5% to 200.57 MXAPJ up 0.9% to 645.76 Nikkei down 0.7% to 29,639.40 Topix down 1.0% to 2,043.55 Hang Seng Index up 1.2% to 24,510.98 Shanghai Composite up 0.4% to 3,642.22 Sensex up 1.4% to 59,728.37 Australia S&P/ASX 200 up 1.0% to 7,370.22 Kospi down 0.4% to 3,127.58 German 10Y yield fell 5.6 bps to -0.306% Euro up 0.4% to $1.1728 Brent Futures up 0.3% to $76.39/bbl Gold spot up 0.0% to $1,768.25 U.S. Dollar Index down 0.33% to 93.16 Top Overnight News from Bloomberg Financial regulators in Beijing issued a broad set of instructions to China Evergrande Group, telling the embattled developer to focus on completing unfinished properties and repaying individual investors while avoiding a near-term default on dollar bonds China’s central bank net-injected the most short- term liquidity in eight months into the financial system, with markets roiled by concerns over China Evergrande Group’s debt crisis Europe’s worst energy crisis in decades could drag deep into the cold months as Russia is unlikely to boost shipments until at least November Business activity in the euro area “markedly” lost momentum in September after demand peaked over the summer and supply chain bottlenecks hurt both services and manufacturers. Surveys of purchasing managers by IHS Markit showed growth in both sectors slowing more than expected, bringing overall activity to a five-month low. Input costs, meanwhile, surged to the highest in 21 years, according to the report The U.K. private sector had its weakest month since the height of the winter lockdown and inflation pressures escalated in September, adding to evidence that the recovery is running into significant headwinds, IHS Markit said The U.K.’s record- breaking debut green bond sale has given debt chief Robert Stheeman conviction on the benefits of an environmental borrowing program. The 10 billion-pound ($13.7 billion) deal this week was the biggest-ever ethical bond sale and the country is already planning another offering next month A more detailed look at global markets courtesy of Newsquaw Asian equity markets traded mostly positive as the region took its cue from the gains in US with the improved global sentiment spurred by some easing of Evergrande concerns and with stocks also unfazed by the marginally more hawkish than anticipated FOMC announcement (detailed above). ASX 200 (+1.0%) was underpinned by outperformance in the commodity-related sectors and strength in defensives, which have more than atoned for the losses in tech and financials, as well as helped markets overlook the record daily COVID-19 infections in Victoria state. Hang Seng (+0.7%) and Shanghai Comp. (+0.6%) were also positive after another respectable liquidity operation by the PBoC and with some relief in Evergrande shares which saw early gains of more than 30% after recent reports suggested a potential restructuring by China’s government and with the Co. Chairman noting that the top priority is to help wealth investors redeem their products, although the majority of the Evergrande gains were then pared and unit China Evergrande New Energy Vehicle fully retraced the initial double-digit advances. KOSPI (-0.5%) was the laggard as it played catch up to the recent losses on its first trading day of the week and amid concerns that COVID cases could surge following the holiday period, while Japanese markets were closed in observance of the Autumnal Equinox Day. China Pumps $17 Billion Into System Amid Evergrande Concerns China Stocks From Property to Tech Jump on Evergrande Respite Philippines Holds Key Rate to Spur Growth Amid Higher Prices Taiwan’s Trade Deal Application Sets Up Showdown With China Top Asian News European equities (Stoxx 600 +0.9%) trade on the front-foot and have extended gains since the cash open with the Stoxx 600 now higher on the week after Monday’s heavy losses. From a macro perspective, price action in Europe has been undeterred by a slowdown in Eurozone PMIs which saw the composite metric slip to 56.1 from 59.0 (exp. 58.5) with IHS Markit noting “an unwelcome combination of sharply slower economic growth and steeply rising prices.” Instead, stocks in the region have taken the cue from a firmer US and Asia-Pac handover with performance in Chinese markets aided by further liquidity injections by the PBoC. Some positivity has also been observed on the Evergrande front amid mounting expectations of a potential restructuring at the company. That said, at the time of writing, it remains unclear what the company’s intentions are for repaying its USD 83.5mln onshore coupon payment. Note, ING highlights that “missing that payment today would still leave a 30-day grace period before this is registered as a default”. The most recent reports via WSJ indicate that Chinese authorities are asking local governments to begin preparations for the potential downfall of Evergrande; however, the article highlights that this is a last resort and Beijing is reluctant to step in. Nonetheless, this article has taken the shine off the mornings risk appetite, though we do remain firmer on the session. Stateside, as the dust settles on yesterday’s FOMC announcement, futures are firmer with outperformance in the RTY (+0.8% vs. ES +0.7%). Sectors in Europe are higher across the board with outperformance in Tech and Autos with the latter aided by gains in Faurecia (+4.6%) who sit at the top of the Stoxx 600 after making an unsurprising cut to its guidance, which will at least provide some clarity on the Co.’s near-term future; in sympathy, Valeo (+6.6) is also a notable gainer in the region. To the downside, Entain (+2.6%) sit at the foot of the Stoxx 600 after recent strong gains with the latest newsflow surrounding the Co. noting that MGM Resorts is considering different methods to acquire control of the BetMGM online gambling business JV, following the DraftKings offer for Entain, according to sources. The agreement between Entain and MGM gives MGM the ability to block any deal with competing businesses; MGM officials believe this grants the leverage to take full control of BetMGM without spending much. Top European News BOE Confronts Rising Prices, Slower Growth: Decision Guide La Banque Postale Eyes Retail, Asset Management M&A in Europe Activist Bluebell Raises Pressure on Glaxo CEO Walmsley Norway Delivers Rate Lift-Off With Next Hike Set for December In FX, not much bang for the Buck even though the FOMC matched the most hawkish market expectations and Fed chair Powell arguably went further by concluding in the post-meeting press conference that substantial progress on the lagging labour front is all but done. Hence, assuming the economy remains on course, tapering could start as soon as November and be completed my the middle of 2022, though he continued to play down tightening prospects irrespective of the more hawkish trajectory implied by the latest SEP dot plots that are now skewed towards at least one hike next year and a cumulative seven over the forecast horizon. However, the Greenback only managed to grind out marginally higher highs overnight, with the index reaching 93.526 vs 93.517 at best yesterday before retreating quite sharply and quickly to 93.138 in advance of jobless claims and Markit’s flash PMIs. CAD/NZD/AUD - The Loonie is leading the comeback charge in major circles and only partially assisted by WTI keeping a firm bid mostly beyond Usd 72/brl, and Usd/Cad may remain contained within 1.2796-50 ahead of Canadian retail sales given decent option expiry interest nearby and protecting the downside (1 bn between 1.2650-65 and 2.7 bn from 1.2620-00). Meanwhile, the Kiwi has secured a firmer grip on the 0.7000 handle to test 0.7050 pre-NZ trade and the Aussie is looking much more comfortable beyond 0.7250 amidst signs of improvement in the flash PMIs, albeit with the services and composite headline indices still some way short of the 50.0 mark. NOK/GBP/EUR/CHF - All firmer, and the Norwegian Crown outperforming following confirmation of the start of rate normalisation by the Norges Bank that also underscored another 25 bp hike in December and further tightening via a loftier rate path. Eur/Nok encountered some support around 10.1000 for a while, but is now below, while the Pound has rebounded against the Dollar and Euro in the run up to the BoE at midday. Cable is back up around 1.3770 and Eur/Gbp circa 0.8580 as Eur/Usd hovers in the low 1.1700 area eyeing multiple and a couple of huge option expiries (at the 1.1700 strike in 4.1 bn, 1.1730 in 1 bn, 1.1745-55 totalling 2.7 bn and 1.8 bn from 1.1790-1.1800). Note, Eurozone and UK flash PMIs did not live up to their name, but hardly impacted. Elsewhere, the Franc is lagging either side of 0.9250 vs the Buck and 1.0835 against the Euro on the back of a dovish SNB Quarterly Review that retained a high Chf valuation and necessity to maintain NIRP, with only minor change in the ordering of the language surrounding intervention. JPY - The Yen is struggling to keep its head afloat of 110.00 vs the Greenback as Treasury yields rebound and risk sentiment remains bullish pre-Japanese CPI and in thinner trading conditions due to the Autumn Equinox holiday. In commodities, WTI and Brent have been choppy throughout the morning in-spite of the broadly constructive risk appetite. Benchmarks spent much of the morning in proximity to the unchanged mark but the most recent Evergrande developments, via WSJ, have dampened sentiment and sent WTI and Brent back into negative territory for the session and printing incremental fresh lows at the time of publication. Back to crude, newsflow has once again centred around energy ministry commentary with Iraq making clear that oil exports will continue to increase. Elsewhere, gas remains at the forefront of focus particularly in the UK/Europe but developments today have been somewhat incremental. On the subject, Citi writes that Asia and Europe Nat. Gas prices could reach USD 100/MMBtu of USD 580/BOE in the winter, under their tail-risk scenario. For metals, its very much a case of more of the same with base-metals supportive, albeit off-best given Evergrande, after a robust APAC session post-FOMC. Given the gas issues, desks highlight that some companies are being forced to suspend/reduce production of items such as steel in Asian/European markets, a narrative that could become pertinent for broader prices if the situation continues. Elsewhere, spot gold and silver are both modestly firmer but remain well within the range of yesterday’s session and are yet to recovery from the pressure seen in wake of the FOMC. US Event Calendar 8:30am: Sept. Initial Jobless Claims, est. 320,000, prior 332,000; Continuing Claims, est. 2.6m, prior 2.67m 8:30am: Aug. Chicago Fed Nat Activity Index, est. 0.50, prior 0.53 9:45am: Sept. Markit US Composite PMI, prior 55.4 9:45am: Sept. Markit US Services PMI, est. 54.9, prior 55.1 9:45am: Sept. Markit US Manufacturing PMI, est. 61.0, prior 61.1 11am: Sept. Kansas City Fed Manf. Activity, est. 25, prior 29 12pm: 2Q US Household Change in Net Wor, prior $5t DB's Jim Reid concludes the overnight wrap My wife was at a parents event at school last night so I had to read three lots of bedtime stories just as the Fed were announcing their policy decision. Peppa Pig, Biff and Kipper, and somebody called Wonder Kid were interspersed with Powell’s press conference live on my phone. It’s fair to say the kids weren’t that impressed by the dot plot and just wanted to join them up. The twins (just turned 4) got their first reading book homework this week and it was a bit sad that one of them was deemed ready to have one with words whereas the other one only pictures. The latter was very upset and cried that his brother had words and he didn’t. That should create even more competitive tension! Back to the dots and yesterday’s Fed meeting was on the hawkish side in terms of the dots and also in terms of Powell’s confidence that the taper could be complete by mid-2022. Powell said that the Fed could begin tapering bond purchases as soon as the November FOMC meeting, in line with our US economists’ forecasts. He left some room for uncertainty, saying they would taper only “If the economy continues to progress broadly in line with expectations, and also the overall situation is appropriate for this.” However he made clear that “the timing and pace of the coming reduction in asset purchases will not be intended to carry a direct signal regarding the timing of interest rate liftoff.” The quarterly “dot plot” showed that the 18 FOMC officials were split on whether to start raising rates next year or not. In June, the median dot indicated no rate increases until 2023, but now 6 members see a 25bps raise next year and 3 members see two such hikes. Their inflation forecasts were also revised up and DB’s Matt Luzzetti writes in his FOMC review (link here) that “If inflation is at or below the Fed's current forecast next year of 2.3% core PCE, liftoff is likely to come in 2023, consistent with our view. However, if inflation proves to be higher with inflation expectations continuing to rise, the first rate increase could well migrate into 2022.” Markets took the overall meeting very much in its stride with the biggest impact probably being a yield curve flattening even if US 10yr Treasury yields traded in just over a 4bp range yesterday and finishing -2.2bps lower at 1.301%. The 5y30y curve flattened -6.7bps to 95.6bps, its flattest level since August 2020, while the 2y10y curve was -4.2bps flatter. So the market seems to believe the more hawkish the Fed gets the more likely they’ll control inflation and/or choke the recovery. The puzzle is that even if the dots are correct, real Fed funds should still be negative and very accommodative historically for all of the forecasting period. As such the market has a very dim view of the ability of the economy to withstand rate hikes or alternatively that the QE technicals are overpowering everything at the moment. In equities, the S&P 500 was up nearly +1.0% 15 minutes prior to the Fed, and then rallied a further 0.5% in the immediate aftermath before a late dip look it back to +0.95%. The late dip meant that the S&P still has not seen a 1% up day since July 23. The index’s rise was driven by cyclicals in particular with energy (+3.17%), semiconductors (-2.20%), and banks (+2.13%) leading the way. Asian markets are mostly trading higher this morning with the Hang Seng (+0.69%), Shanghai Comp (+0.58%), ASX (+1.03%) and India’s Nifty (+0.81%) all up. The Kospi (-0.36%) is trading lower though and is still catching up from the early week holidays. Japan’s markets are closed for a holiday today. Futures on the S&P 500 are up +0.25% while those on the Stoxx 50 are up +0.49%. There is no new news on the Evergrande debt crisis however markets participants are likely to pay attention to whether the group is able to make interest rate payment on its 5 year dollar note today after the group had said yesterday that it resolved a domestic bond coupon by negotiations which was also due today. As we highlighted in our CoTD flash poll conducted earlier this week, market participants are not too worried about a wider fallout from the Evergrande crisis and even the Hang Seng Properties index is up +3.93% this morning and is largely back at the levels before the big Monday sell-off of -6.69%. Overnight we have received flash PMIs for Australia which improved as parts of the country have eased the coronavirus restrictions. The services reading came in at 44.9 (vs. 42.9 last month) and the manufacturing print was even stronger at 57.3 (vs. 52.0 last month). Japan’s flash PMIs will be out tomorrow due to today’s holiday. Ahead of the Fed, markets had continued to rebound from their declines earlier in the week, with Europe’s STOXX 600 gaining +0.99% to narrowly put the index in positive territory for the week. This continues the theme of a relative outperformance among European equities compared to the US, with the STOXX 600 having outpaced the S&P 500 for 5 consecutive sessions now, though obviously by a slim margin yesterday. Sovereign bonds in Europe also posted gains, with yields on 10yr bunds (-0.7bps), OATs (-1.0bps) and BTPs (-3.2bps) all moving lower. Furthermore, there was another tightening in peripheral spreads, with the gap in Italian 10yr yields over bunds falling to 98.8bps yesterday, less than half a basis point away from its tightest level since early April. Moving to fiscal and with Democrats seemingly unable to pass the $3.5 trillion Biden budget plan by Monday, when the House is set to vote on the bipartisan infrastructure bill, Republican leadership is calling on their members to vote against the bipartisan bill in hopes of delaying the process further. While the there is still a high likelihood the measure will eventually get passed, time is becoming a factor. Congress now has just over a week to get a government funding bill through both chambers of congress as well as raise the debt ceiling by next month. Republicans have told Democrats to do the latter in a partisan manner and include it in the reconciliation process which could mean that a significant portion of the Biden economic agenda – mostly encapsulated in the $3.5 trillion over 10 year budget – may have to be cut down to get the entire Democratic caucus on board. Looking ahead, an event to watch out for today will be the Bank of England’s policy decision at 12:00 London time, where our economists write (link here) that they expect no change in the policy settings. However, they do expect a reaffirmation of the BoE’s updated forward guidance that some tightening will be needed over the next few years to keep inflation in check, even if it’s too early to expect a further hawkish pivot at this stage. Staying on the UK, two further energy suppliers (Avro Energy and Green Supplier) ceased trading yesterday amidst the surge in gas prices, with the two supplying 2.9% of domestic customers between them. We have actually seen a modest fall in European natural gas prices over the last couple of days, with the benchmark future down -4.81% since its close on Monday, although it’s worth noting that still leaves them up +75.90% since the start of August alone. There wasn’t much data to speak of yesterday, though US existing home sales fell to an annualised rate of 5.88 in August (vs. 5.89m expected). Separately, the European Commission’s advance consumer confidence reading for the Euro Area unexpectedly rose to -4.0 in September (vs. -5.9 expected). To the day ahead now, the data highlights include the September flash PMIs from around the world, while in the US there’s the weekly initial jobless claims, the Chicago Fed’s national activity index for August, and the Kansas City fed’s manufacturing activity index for September. From central banks, there’ll be a monetary policy decision from the Bank of England, while the ECB will be publishing their Economic Bulletin and the ECB’s Elderson will also speak. From emerging markets, there’ll also be monetary policy decisions from the Central Bank of Turkey and the South African Reserve Bank. Finally in Germany, there’s an election debate with the lead candidates from the Bundestag parties. Tyler Durden Thu, 09/23/2021 - 08:13.....»»

Category: blogSource: zerohedgeSep 23rd, 2021

Michael Cohen says Trump is bluffing about another presidential run because he can"t "stomach the notion of being a 2-time loser"

Cohen told Insider that Trump wanted to keep raising money and retain "some semblance of power, importance, and relevance, none of which he has." Michael Cohen. Spencer Platt/Getty Images Michael Cohen said Trump was bluffing about a 2024 run in part because "he's making more money doing that than anything he has ever done." Trump wants to retain "some semblance of power, importance, and relevance," Cohen said, "none of which he has." Cohen said Trump wouldn't run because he can't "stomach the notion of being a two-time loser." See more stories on Insider's business page. Former President Donald Trump's former lawyer and fixer said on Wednesday that he thought Trump was bluffing about launching another presidential run."His insatiable need for attention is one reason he continues to flaunt this disingenuous 2024 run," Michael Cohen told Insider in an interview. "The other is he's making more money doing that than anything he has ever done before."Trump has repeatedly teased a 2024 campaign since leaving office in January. The former president raised more money than any other Republican in the first half of the year and had a war chest of more than $100 million by the end of June, The New York Times reported over the summer, citing federal campaign filings.Despite claiming the 2020 election was rigged and promising to help more Republicans get elected, Trump hasn't spent any of the money on audits or GOP-led campaigns, according to Politico. He's largely used it to promote his own interests, cover event and travel expenses, and pay the salaries of his aides and advisors, the report said. He's also used some of the funds to cover legal expenses in his baseless effort to overturn the 2020 election results.Cohen on Wednesday described Trump as "the greatest grifter in the history of American politics," adding that Trump would ultimately come up with a "handful of reasons why he won't run again and blame others for his decision.""He'll say he's not going to run again because of bipartisan hatred for him or because of the Democrats or because he doesn't want to put his family through any more," Cohen said. "He cannot stomach the notion of being a two-time loser, but he will continue to grift until the very last second."A spokesperson for Trump did not immediately respond to a request for comment.The former president is "trying to retain some semblance of power, importance, and relevance, none of which he has," said Cohen, who is serving a three-year prison sentence after pleading guilty to an array of felonies in 2018.He pleaded guilty in August 2018 to eight counts of campaign-finance violations, tax evasion, and wire fraud. He also pleaded guilty that November to one felony count of lying to Congress as part of the special counsel Robert Mueller's investigation into Russia's interference in the 2016 US election.Trump defended Cohen earlier in 2018, describing the FBI's raids on his home and office as "disgraceful" and a "total witch hunt." But the president changed his tune when it surfaced that Cohen was cooperating with the feds - he called his former lawyer and longtime fixer a "rat," a term commonly used by Mafia bosses to describe former loyalists who flip on them.Cohen postponed his congressional testimony in early 2019; his legal team cited "ongoing threats against his family from President Trump" and Rudy Giuliani. Trump had repeatedly tweeted that Cohen's father-in-law should be investigated, a statement Cohen's lawyer and some Democratic lawmakers interpreted as witness intimidation.Cohen argued last December that he should be released from home confinement early under the First Step Act, a criminal-justice-reform bill that Trump signed into law in 2018. But prosecutors said in March that Cohen should serve the rest of his sentence in home confinement.Cohen said he was "frustrated" and "exhausted" but looked forward to being released on November 22.Asked about the first thing he'd do after completing his sentence, Cohen joked, "Go to Disneyland.""In all honesty, I don't know," he said. "In 60 days I have to rebuild my life, which is not easy when you're 55 years old."That said, Cohen has begun laying the groundwork for a return to public life. In addition to frequently appearing on cable news to comment on the latest developments in Trumpworld, Cohen launched a podcast, "Mea Culpa," described as part of his effort to "right the wrongs he perpetuated on behalf of his boss."The podcast's latest episode featured Stormy Daniels, the adult-film star whose allegations of an affair with Trump were at the center of Cohen's first guilty plea in 2018. Once he gets out of home confinement, Cohen will take "Mea Culpa" on a "live national tour" to mark the end of his prison sentence, a press release said.Read the original article on Business Insider.....»»

Category: smallbizSource: nytSep 22nd, 2021

Michael Cohen says Trump is bluffing about another presidential run because he can"t "stomach the notion of being a two-time loser"

Cohen told Insider that Trump wants to keep raising money and retain some "semblance of power, importance, and relevance, none of which he has." Michael Cohen. Spencer Platt/Getty Images Michael Cohen said Trump is bluffing about a 2024 run in part because "he's making more money doing that than anything he has ever done." He told Insider Trump is also teasing a campaign to retain "some semblance of power, importance and relevance, none of which he has." But in the end, Cohen said Trump won't run because he can't "stomach the notion of being a two-time loser." See more stories on Insider's business page. Former President Donald Trump's longtime former lawyer and fixer said Wednesday that he thinks Trump is bluffing about launching another presidential run."His insatiable need for attention is one reason he continues to flaunt this disingenuous 2024 run," Michael Cohen told Insider in an interview. "The other is he's making more money doing that than anything he has ever done before."Trump has repeatedly teased a potential 2024 campaign in the months since he left office in January. The former president raised more money than any other Republican in the first half of the year and had a war chest of more than $100 million by the end of June, The New York Times reported over the summer, citing federal campaign filings.But despite claiming the 2020 election was rigged and promising to help more Republicans get elected, Trump hasn't spent any of the money on audits or GOP-led campaigns, according to Politico. Instead, he's largely spent the money to promote his own interests, cover event and travel expenses, and pay the salaries of his aides and advisors, the report said. He's also used some of the funds to cover legal expenses in his baseless effort to overturn the 2020 election results.Cohen on Wednesday described Trump as "the greatest grifter in the history of American politics," adding that he'll ultimately come up with a "handful of reasons why he won't run again and blame others for his decision.""He'll say he's not going to run again because of bipartisan hatred for him or because of the Democrats or because he doesn't want to put his family through any more," Cohen said of Trump. "He cannot stomach the notion of being a two-time loser, but he will continue to grift until the very last second."A spokesperson for Trump did not immediately respond to a request for comment.The former president is "trying to retain some semblance of power, importance, and relevance, none of which he has," said Cohen, who is currently serving out a three-year prison sentence after pleading guilty to an array of felonies.He pleaded guilty in August 2018 to eight counts of campaign finance violations, tax evasion, and wire fraud. He also pleaded guilty that November to one felony count of lying to Congress as part of the special counsel Robert Mueller's investigation into Russia's interference in the 2016 US election.Trump initially defended Cohen earlier in 2018, calling the FBI's raids on his home and office "disgraceful" and a "total witch hunt." But the president quickly changed tune when it surfaced that Cohen was cooperating with the feds, calling his former lawyer and longtime fixer a "rat," a term commonly used by mafia bosses to describe former loyalists who flip on them.Cohen also postponed his congressional testimony in early 2019, citing "ongoing threats against his family from President Trump" and Giuliani. His statement came after Trump repeatedly tweeted that Cohen's father-in-law should be investigated, a statement Cohen's lawyer and some Democratic lawmakers interpreted as witness intimidation.Cohen argued last December that he should be released from home confinement early under the First Step Act, a criminal justice reform bill that Trump signed into law in 2018.But prosecutors said in March that Cohen should continue serving out the rest of his sentence in home confinement. The president's former lawyer and fixer said he's "frustrated" and "exhausted" but looks forward to being released on November 22.Asked about the first thing he'll do after completing his sentence, Cohen joked: "Go to Disneyland.""In all honesty, I don't know," he said. "In sixty days, I have to rebuild my life, which is not easy when you're 55 years old."That said, Cohen has already begun laying the groundwork for a return to public life. In addition to frequently appearing on cable news to comment on the latest developments in Trumpworld, Cohen also launched a podcast, called "Mea Culpa," which he described as being part of his effort to "right the wrongs he perpetuated on behalf of his former boss."The podcast's latest episode featured Stormy Daniels, the adult film star whose alleged affair with Trump was at the center of Cohen's first guilty plea in 2018. Once he gets out of home confinement, Cohen will take Mea Culpa on a "live national tour" to mark the end of his prison sentence, according to a press release.Read the original article on Business Insider.....»»

Category: worldSource: nytSep 22nd, 2021

Donald Trump Jr. Says His Father Would Be ‘Stupid’ To Talk to Mueller in Russia Probe

Donald Trump Jr. told Fox and Friends that Trump shouldn't sit down with special counsel Robert Mueller and calls Russia probe a witch hunt against the president......»»

Category: topSource: newsweekJun 14th, 2018

"Damn You To Hell, You Will Not Destroy America" - Here Is The "Spartacus COVID Letter" That"s Gone Viral

"Damn You To Hell, You Will Not Destroy America" - Here Is The 'Spartacus COVID Letter' That's Gone Viral Via The Automatic Earth blog, This is an anonymously posted document by someone who calls themselves Spartacus. Because it’s anonymous, I can’t contact them to ask for permission to publish. So I hesitated for a while, but it’s simply the best document I’ve seen on Covid, vaccines, etc. Whoever Spartacus is, they have a very elaborate knowledge in “the field”. If you want to know a lot more about the no. 1 issue in the world today, read it. And don’t worry if you don’t understand every single word, neither do I. But I learned a lot. The original PDF doc is here: Covid19 – The Spartacus Letter Hello, My name is Spartacus, and I’ve had enough. We have been forced to watch America and the Free World spin into inexorable decline due to a biowarfare attack. We, along with countless others, have been victimized and gaslit by propaganda and psychological warfare operations being conducted by an unelected, unaccountable Elite against the American people and our allies. Our mental and physical health have suffered immensely over the course of the past year and a half. We have felt the sting of isolation, lockdown, masking, quarantines, and other completely nonsensical acts of healthcare theater that have done absolutely nothing to protect the health or wellbeing of the public from the ongoing COVID-19 pandemic. Now, we are watching the medical establishment inject literal poison into millions of our fellow Americans without so much as a fight. We have been told that we will be fired and denied our livelihoods if we refuse to vaccinate. This was the last straw. We have spent thousands of hours analyzing leaked footage from Wuhan, scientific papers from primary sources, as well as the paper trails left by the medical establishment. What we have discovered would shock anyone to their core. First, we will summarize our findings, and then, we will explain them in detail. References will be placed at the end. Summary: COVID-19 is a blood and blood vessel disease. SARS-CoV-2 infects the lining of human blood vessels, causing them to leak into the lungs. Current treatment protocols (e.g. invasive ventilation) are actively harmful to patients, accelerating oxidative stress and causing severe VILI (ventilator-induced lung injuries). The continued use of ventilators in the absence of any proven medical benefit constitutes mass murder. Existing countermeasures are inadequate to slow the spread of what is an aerosolized and potentially wastewater-borne virus, and constitute a form of medical theater. Various non-vaccine interventions have been suppressed by both the media and the medical establishment in favor of vaccines and expensive patented drugs. The authorities have denied the usefulness of natural immunity against COVID-19, despite the fact that natural immunity confers protection against all of the virus’s proteins, and not just one. Vaccines will do more harm than good. The antigen that these vaccines are based on, SARS-CoV- 2 Spike, is a toxic protein. SARS-CoV-2 may have ADE, or antibody-dependent enhancement; current antibodies may not neutralize future strains, but instead help them infect immune cells. Also, vaccinating during a pandemic with a leaky vaccine removes the evolutionary pressure for a virus to become less lethal. There is a vast and appalling criminal conspiracy that directly links both Anthony Fauci and Moderna to the Wuhan Institute of Virology. COVID-19 vaccine researchers are directly linked to scientists involved in brain-computer interface (“neural lace”) tech, one of whom was indicted for taking grant money from China. Independent researchers have discovered mysterious nanoparticles inside the vaccines that are not supposed to be present. The entire pandemic is being used as an excuse for a vast political and economic transformation of Western society that will enrich the already rich and turn the rest of us into serfs and untouchables. COVID-19 Pathophysiology and Treatments: COVID-19 is not a viral pneumonia. It is a viral vascular endotheliitis and attacks the lining of blood vessels, particularly the small pulmonary alveolar capillaries, leading to endothelial cell activation and sloughing, coagulopathy, sepsis, pulmonary edema, and ARDS-like symptoms. This is a disease of the blood and blood vessels. The circulatory system. Any pneumonia that it causes is secondary to that. In severe cases, this leads to sepsis, blood clots, and multiple organ failure, including hypoxic and inflammatory damage to various vital organs, such as the brain, heart, liver, pancreas, kidneys, and intestines. Some of the most common laboratory findings in COVID-19 are elevated D-dimer, elevated prothrombin time, elevated C-reactive protein, neutrophilia, lymphopenia, hypocalcemia, and hyperferritinemia, essentially matching a profile of coagulopathy and immune system hyperactivation/immune cell exhaustion. COVID-19 can present as almost anything, due to the wide tropism of SARS-CoV-2 for various tissues in the body’s vital organs. While its most common initial presentation is respiratory illness and flu-like symptoms, it can present as brain inflammation, gastrointestinal disease, or even heart attack or pulmonary embolism. COVID-19 is more severe in those with specific comorbidities, such as obesity, diabetes, and hypertension. This is because these conditions involve endothelial dysfunction, which renders the circulatory system more susceptible to infection and injury by this particular virus. The vast majority of COVID-19 cases are mild and do not cause significant disease. In known cases, there is something known as the 80/20 rule, where 80% of cases are mild and 20% are severe or critical. However, this ratio is only correct for known cases, not all infections. The number of actual infections is much, much higher. Consequently, the mortality and morbidity rate is lower. However, COVID-19 spreads very quickly, meaning that there are a significant number of severely-ill and critically-ill patients appearing in a short time frame. In those who have critical COVID-19-induced sepsis, hypoxia, coagulopathy, and ARDS, the most common treatments are intubation, injected corticosteroids, and blood thinners. This is not the correct treatment for COVID-19. In severe hypoxia, cellular metabolic shifts cause ATP to break down into hypoxanthine, which, upon the reintroduction of oxygen, causes xanthine oxidase to produce tons of highly damaging radicals that attack tissue. This is called ischemia-reperfusion injury, and it’s why the majority of people who go on a ventilator are dying. In the mitochondria, succinate buildup due to sepsis does the same exact thing; when oxygen is reintroduced, it makes superoxide radicals. Make no mistake, intubation will kill people who have COVID-19. The end-stage of COVID-19 is severe lipid peroxidation, where fats in the body start to “rust” due to damage by oxidative stress. This drives autoimmunity. Oxidized lipids appear as foreign objects to the immune system, which recognizes and forms antibodies against OSEs, or oxidation-specific epitopes. Also, oxidized lipids feed directly into pattern recognition receptors, triggering even more inflammation and summoning even more cells of the innate immune system that release even more destructive enzymes. This is similar to the pathophysiology of Lupus. COVID-19’s pathology is dominated by extreme oxidative stress and neutrophil respiratory burst, to the point where hemoglobin becomes incapable of carrying oxygen due to heme iron being stripped out of heme by hypochlorous acid. No amount of supplemental oxygen can oxygenate blood that chemically refuses to bind O2. The breakdown of the pathology is as follows: SARS-CoV-2 Spike binds to ACE2. Angiotensin Converting Enzyme 2 is an enzyme that is part of the renin-angiotensin-aldosterone system, or RAAS. The RAAS is a hormone control system that moderates fluid volume in the body and in the bloodstream (i.e. osmolarity) by controlling salt retention and excretion. This protein, ACE2, is ubiquitous in every part of the body that interfaces with the circulatory system, particularly in vascular endothelial cells and pericytes, brain astrocytes, renal tubules and podocytes, pancreatic islet cells, bile duct and intestinal epithelial cells, and the seminiferous ducts of the testis, all of which SARS-CoV-2 can infect, not just the lungs. SARS-CoV-2 infects a cell as follows: SARS-CoV-2 Spike undergoes a conformational change where the S1 trimers flip up and extend, locking onto ACE2 bound to the surface of a cell. TMPRSS2, or transmembrane protease serine 2, comes along and cuts off the heads of the Spike, exposing the S2 stalk-shaped subunit inside. The remainder of the Spike undergoes a conformational change that causes it to unfold like an extension ladder, embedding itself in the cell membrane. Then, it folds back upon itself, pulling the viral membrane and the cell membrane together. The two membranes fuse, with the virus’s proteins migrating out onto the surface of the cell. The SARS-CoV-2 nucleocapsid enters the cell, disgorging its genetic material and beginning the viral replication process, hijacking the cell’s own structures to produce more virus. SARS-CoV-2 Spike proteins embedded in a cell can actually cause human cells to fuse together, forming syncytia/MGCs (multinuclear giant cells). They also have other pathogenic, harmful effects. SARS-CoV- 2’s viroporins, such as its Envelope protein, act as calcium ion channels, introducing calcium into infected cells. The virus suppresses the natural interferon response, resulting in delayed inflammation. SARS-CoV-2 N protein can also directly activate the NLRP3 inflammasome. Also, it suppresses the Nrf2 antioxidant pathway. The suppression of ACE2 by binding with Spike causes a buildup of bradykinin that would otherwise be broken down by ACE2. This constant calcium influx into the cells results in (or is accompanied by) noticeable hypocalcemia, or low blood calcium, especially in people with Vitamin D deficiencies and pre-existing endothelial dysfunction. Bradykinin upregulates cAMP, cGMP, COX, and Phospholipase C activity. This results in prostaglandin release and vastly increased intracellular calcium signaling, which promotes highly aggressive ROS release and ATP depletion. NADPH oxidase releases superoxide into the extracellular space. Superoxide radicals react with nitric oxide to form peroxynitrite. Peroxynitrite reacts with the tetrahydrobiopterin cofactor needed by endothelial nitric oxide synthase, destroying it and “uncoupling” the enzymes, causing nitric oxide synthase to synthesize more superoxide instead. This proceeds in a positive feedback loop until nitric oxide bioavailability in the circulatory system is depleted. Dissolved nitric oxide gas produced constantly by eNOS serves many important functions, but it is also antiviral against SARS-like coronaviruses, preventing the palmitoylation of the viral Spike protein and making it harder for it to bind to host receptors. The loss of NO allows the virus to begin replicating with impunity in the body. Those with endothelial dysfunction (i.e. hypertension, diabetes, obesity, old age, African-American race) have redox equilibrium issues to begin with, giving the virus an advantage. Due to the extreme cytokine release triggered by these processes, the body summons a great deal of neutrophils and monocyte-derived alveolar macrophages to the lungs. Cells of the innate immune system are the first-line defenders against pathogens. They work by engulfing invaders and trying to attack them with enzymes that produce powerful oxidants, like SOD and MPO. Superoxide dismutase takes superoxide and makes hydrogen peroxide, and myeloperoxidase takes hydrogen peroxide and chlorine ions and makes hypochlorous acid, which is many, many times more reactive than sodium hypochlorite bleach. Neutrophils have a nasty trick. They can also eject these enzymes into the extracellular space, where they will continuously spit out peroxide and bleach into the bloodstream. This is called neutrophil extracellular trap formation, or, when it becomes pathogenic and counterproductive, NETosis. In severe and critical COVID-19, there is actually rather severe NETosis. Hypochlorous acid building up in the bloodstream begins to bleach the iron out of heme and compete for O2 binding sites. Red blood cells lose the ability to transport oxygen, causing the sufferer to turn blue in the face. Unliganded iron, hydrogen peroxide, and superoxide in the bloodstream undergo the Haber- Weiss and Fenton reactions, producing extremely reactive hydroxyl radicals that violently strip electrons from surrounding fats and DNA, oxidizing them severely. This condition is not unknown to medical science. The actual name for all of this is acute sepsis. We know this is happening in COVID-19 because people who have died of the disease have noticeable ferroptosis signatures in their tissues, as well as various other oxidative stress markers such as nitrotyrosine, 4-HNE, and malondialdehyde. When you intubate someone with this condition, you are setting off a free radical bomb by supplying the cells with O2. It’s a catch-22, because we need oxygen to make Adenosine Triphosphate (that is, to live), but O2 is also the precursor of all these damaging radicals that lead to lipid peroxidation. The correct treatment for severe COVID-19 related sepsis is non-invasive ventilation, steroids, and antioxidant infusions. Most of the drugs repurposed for COVID-19 that show any benefit whatsoever in rescuing critically-ill COVID-19 patients are antioxidants. N-acetylcysteine, melatonin, fluvoxamine, budesonide, famotidine, cimetidine, and ranitidine are all antioxidants. Indomethacin prevents iron- driven oxidation of arachidonic acid to isoprostanes. There are powerful antioxidants such as apocynin that have not even been tested on COVID-19 patients yet which could defang neutrophils, prevent lipid peroxidation, restore endothelial health, and restore oxygenation to the tissues. Scientists who know anything about pulmonary neutrophilia, ARDS, and redox biology have known or surmised much of this since March 2020. In April 2020, Swiss scientists confirmed that COVID-19 was a vascular endotheliitis. By late 2020, experts had already concluded that COVID-19 causes a form of viral sepsis. They also know that sepsis can be effectively treated with antioxidants. None of this information is particularly new, and yet, for the most part, it has not been acted upon. Doctors continue to use damaging intubation techniques with high PEEP settings despite high lung compliance and poor oxygenation, killing an untold number of critically ill patients with medical malpractice. Because of the way they are constructed, Randomized Control Trials will never show any benefit for any antiviral against COVID-19. Not Remdesivir, not Kaletra, not HCQ, and not Ivermectin. The reason for this is simple; for the patients that they have recruited for these studies, such as Oxford’s ludicrous RECOVERY study, the intervention is too late to have any positive effect. The clinical course of COVID-19 is such that by the time most people seek medical attention for hypoxia, their viral load has already tapered off to almost nothing. If someone is about 10 days post-exposure and has already been symptomatic for five days, there is hardly any virus left in their bodies, only cellular damage and derangement that has initiated a hyperinflammatory response. It is from this group that the clinical trials for antivirals have recruited, pretty much exclusively. In these trials, they give antivirals to severely ill patients who have no virus in their bodies, only a delayed hyperinflammatory response, and then absurdly claim that antivirals have no utility in treating or preventing COVID-19. These clinical trials do not recruit people who are pre-symptomatic. They do not test pre-exposure or post-exposure prophylaxis. This is like using a defibrillator to shock only flatline, and then absurdly claiming that defibrillators have no medical utility whatsoever when the patients refuse to rise from the dead. The intervention is too late. These trials for antivirals show systematic, egregious selection bias. They are providing a treatment that is futile to the specific cohort they are enrolling. India went against the instructions of the WHO and mandated the prophylactic usage of Ivermectin. They have almost completely eradicated COVID-19. The Indian Bar Association of Mumbai has brought criminal charges against WHO Chief Scientist Dr. Soumya Swaminathan for recommending against the use of Ivermectin. Ivermectin is not “horse dewormer”. Yes, it is sold in veterinary paste form as a dewormer for animals. It has also been available in pill form for humans for decades, as an antiparasitic drug. The media have disingenuously claimed that because Ivermectin is an antiparasitic drug, it has no utility as an antivirus. This is incorrect. Ivermectin has utility as an antiviral. It blocks importin, preventing nuclear import, effectively inhibiting viral access to cell nuclei. Many drugs currently on the market have multiple modes of action. Ivermectin is one such drug. It is both antiparasitic and antiviral. In Bangladesh, Ivermectin costs $1.80 for an entire 5-day course. Remdesivir, which is toxic to the liver, costs $3,120 for a 5-day course of the drug. Billions of dollars of utterly useless Remdesivir were sold to our governments on the taxpayer’s dime, and it ended up being totally useless for treating hyperinflammatory COVID-19. The media has hardly even covered this at all. The opposition to the use of generic Ivermectin is not based in science. It is purely financially and politically-motivated. An effective non-vaccine intervention would jeopardize the rushed FDA approval of patented vaccines and medicines for which the pharmaceutical industry stands to rake in billions upon billions of dollars in sales on an ongoing basis. The majority of the public are scientifically illiterate and cannot grasp what any of this even means, thanks to a pathetic educational system that has miseducated them. You would be lucky to find 1 in 100 people who have even the faintest clue what any of this actually means. COVID-19 Transmission: COVID-19 is airborne. The WHO carried water for China by claiming that the virus was only droplet- borne. Our own CDC absurdly claimed that it was mostly transmitted by fomite-to-face contact, which, given its rapid spread from Wuhan to the rest of the world, would have been physically impossible. The ridiculous belief in fomite-to-face being a primary mode of transmission led to the use of surface disinfection protocols that wasted time, energy, productivity, and disinfectant. The 6-foot guidelines are absolutely useless. The minimum safe distance to protect oneself from an aerosolized virus is to be 15+ feet away from an infected person, no closer. Realistically, no public transit is safe. Surgical masks do not protect you from aerosols. The virus is too small and the filter media has too large of gaps to filter it out. They may catch respiratory droplets and keep the virus from being expelled by someone who is sick, but they do not filter a cloud of infectious aerosols if someone were to walk into said cloud. The minimum level of protection against this virus is quite literally a P100 respirator, a PAPR/CAPR, or a 40mm NATO CBRN respirator, ideally paired with a full-body tyvek or tychem suit, gloves, and booties, with all the holes and gaps taped. Live SARS-CoV-2 may potentially be detected in sewage outflows, and there may be oral-fecal transmission. During the SARS outbreak in 2003, in the Amoy Gardens incident, hundreds of people were infected by aerosolized fecal matter rising from floor drains in their apartments. COVID-19 Vaccine Dangers: The vaccines for COVID-19 are not sterilizing and do not prevent infection or transmission. They are “leaky” vaccines. This means they remove the evolutionary pressure on the virus to become less lethal. It also means that the vaccinated are perfect carriers. In other words, those who are vaccinated are a threat to the unvaccinated, not the other way around. All of the COVID-19 vaccines currently in use have undergone minimal testing, with highly accelerated clinical trials. Though they appear to limit severe illness, the long-term safety profile of these vaccines remains unknown. Some of these so-called “vaccines” utilize an untested new technology that has never been used in vaccines before. Traditional vaccines use weakened or killed virus to stimulate an immune response. The Moderna and Pfizer-BioNTech vaccines do not. They are purported to consist of an intramuscular shot containing a suspension of lipid nanoparticles filled with messenger RNA. The way they generate an immune response is by fusing with cells in a vaccine recipient’s shoulder, undergoing endocytosis, releasing their mRNA cargo into those cells, and then utilizing the ribosomes in those cells to synthesize modified SARS-CoV-2 Spike proteins in-situ. These modified Spike proteins then migrate to the surface of the cell, where they are anchored in place by a transmembrane domain. The adaptive immune system detects the non-human viral protein being expressed by these cells, and then forms antibodies against that protein. This is purported to confer protection against the virus, by training the adaptive immune system to recognize and produce antibodies against the Spike on the actual virus. The J&J and AstraZeneca vaccines do something similar, but use an adenovirus vector for genetic material delivery instead of a lipid nanoparticle. These vaccines were produced or validated with the aid of fetal cell lines HEK-293 and PER.C6, which people with certain religious convictions may object strongly to. SARS-CoV-2 Spike is a highly pathogenic protein on its own. It is impossible to overstate the danger presented by introducing this protein into the human body. It is claimed by vaccine manufacturers that the vaccine remains in cells in the shoulder, and that SARS- CoV-2 Spike produced and expressed by these cells from the vaccine’s genetic material is harmless and inert, thanks to the insertion of prolines in the Spike sequence to stabilize it in the prefusion conformation, preventing the Spike from becoming active and fusing with other cells. However, a pharmacokinetic study from Japan showed that the lipid nanoparticles and mRNA from the Pfizer vaccine did not stay in the shoulder, and in fact bioaccumulated in many different organs, including the reproductive organs and adrenal glands, meaning that modified Spike is being expressed quite literally all over the place. These lipid nanoparticles may trigger anaphylaxis in an unlucky few, but far more concerning is the unregulated expression of Spike in various somatic cell lines far from the injection site and the unknown consequences of that. Messenger RNA is normally consumed right after it is produced in the body, being translated into a protein by a ribosome. COVID-19 vaccine mRNA is produced outside the body, long before a ribosome translates it. In the meantime, it could accumulate damage if inadequately preserved. When a ribosome attempts to translate a damaged strand of mRNA, it can become stalled. When this happens, the ribosome becomes useless for translating proteins because it now has a piece of mRNA stuck in it, like a lace card in an old punch card reader. The whole thing has to be cleaned up and new ribosomes synthesized to replace it. In cells with low ribosome turnover, like nerve cells, this can lead to reduced protein synthesis, cytopathic effects, and neuropathies. Certain proteins, including SARS-CoV-2 Spike, have proteolytic cleavage sites that are basically like little dotted lines that say “cut here”, which attract a living organism’s own proteases (essentially, molecular scissors) to cut them. There is a possibility that S1 may be proteolytically cleaved from S2, causing active S1 to float away into the bloodstream while leaving the S2 “stalk” embedded in the membrane of the cell that expressed the protein. SARS-CoV-2 Spike has a Superantigenic region (SAg), which may promote extreme inflammation. Anti-Spike antibodies were found in one study to function as autoantibodies and attack the body’s own cells. Those who have been immunized with COVID-19 vaccines have developed blood clots, myocarditis, Guillain-Barre Syndrome, Bell’s Palsy, and multiple sclerosis flares, indicating that the vaccine promotes autoimmune reactions against healthy tissue. SARS-CoV-2 Spike does not only bind to ACE2. It was suspected to have regions that bind to basigin, integrins, neuropilin-1, and bacterial lipopolysaccharides as well. SARS-CoV-2 Spike, on its own, can potentially bind any of these things and act as a ligand for them, triggering unspecified and likely highly inflammatory cellular activity. SARS-CoV-2 Spike contains an unusual PRRA insert that forms a furin cleavage site. Furin is a ubiquitous human protease, making this an ideal property for the Spike to have, giving it a high degree of cell tropism. No wild-type SARS-like coronaviruses related to SARS-CoV-2 possess this feature, making it highly suspicious, and perhaps a sign of human tampering. SARS-CoV-2 Spike has a prion-like domain that enhances its infectiousness. The Spike S1 RBD may bind to heparin-binding proteins and promote amyloid aggregation. In humans, this could lead to Parkinson’s, Lewy Body Dementia, premature Alzheimer’s, or various other neurodegenerative diseases. This is very concerning because SARS-CoV-2 S1 is capable of injuring and penetrating the blood-brain barrier and entering the brain. It is also capable of increasing the permeability of the blood-brain barrier to other molecules. SARS-CoV-2, like other betacoronaviruses, may have Dengue-like ADE, or antibody-dependent enhancement of disease. For those who aren’t aware, some viruses, including betacoronaviruses, have a feature called ADE. There is also something called Original Antigenic Sin, which is the observation that the body prefers to produce antibodies based on previously-encountered strains of a virus over newly- encountered ones. In ADE, antibodies from a previous infection become non-neutralizing due to mutations in the virus’s proteins. These non-neutralizing antibodies then act as trojan horses, allowing live, active virus to be pulled into macrophages through their Fc receptor pathways, allowing the virus to infect immune cells that it would not have been able to infect before. This has been known to happen with Dengue Fever; when someone gets sick with Dengue, recovers, and then contracts a different strain, they can get very, very ill. If someone is vaccinated with mRNA based on the Spike from the initial Wuhan strain of SARS-CoV-2, and then they become infected with a future, mutated strain of the virus, they may become severely ill. In other words, it is possible for vaccines to sensitize someone to disease. There is a precedent for this in recent history. Sanofi’s Dengvaxia vaccine for Dengue failed because it caused immune sensitization in people whose immune systems were Dengue-naive. In mice immunized against SARS-CoV and challenged with the virus, a close relative of SARS-CoV-2, they developed immune sensitization, Th2 immunopathology, and eosinophil infiltration in their lungs. We have been told that SARS-CoV-2 mRNA vaccines cannot be integrated into the human genome, because messenger RNA cannot be turned back into DNA. This is false. There are elements in human cells called LINE-1 retrotransposons, which can indeed integrate mRNA into a human genome by endogenous reverse transcription. Because the mRNA used in the vaccines is stabilized, it hangs around in cells longer, increasing the chances for this to happen. If the gene for SARS-CoV-2 Spike is integrated into a portion of the genome that is not silent and actually expresses a protein, it is possible that people who take this vaccine may continuously express SARS-CoV-2 Spike from their somatic cells for the rest of their lives. By inoculating people with a vaccine that causes their bodies to produce Spike in-situ, they are being inoculated with a pathogenic protein. A toxin that may cause long-term inflammation, heart problems, and a raised risk of cancers. In the long-term, it may also potentially lead to premature neurodegenerative disease. Absolutely nobody should be compelled to take this vaccine under any circumstances, and in actual fact, the vaccination campaign must be stopped immediately. COVID-19 Criminal Conspiracy: The vaccine and the virus were made by the same people. In 2014, there was a moratorium on SARS gain-of-function research that lasted until 2017. This research was not halted. Instead, it was outsourced, with the federal grants being laundered through NGOs. Ralph Baric is a virologist and SARS expert at UNC Chapel Hill in North Carolina. This is who Anthony Fauci was referring to when he insisted, before Congress, that if any gain-of-function research was being conducted, it was being conducted in North Carolina. This was a lie. Anthony Fauci lied before Congress. A felony. Ralph Baric and Shi Zhengli are colleagues and have co-written papers together. Ralph Baric mentored Shi Zhengli in his gain-of-function manipulation techniques, particularly serial passage, which results in a virus that appears as if it originated naturally. In other words, deniable bioweapons. Serial passage in humanized hACE2 mice may have produced something like SARS-CoV-2. The funding for the gain-of-function research being conducted at the Wuhan Institute of Virology came from Peter Daszak. Peter Daszak runs an NGO called EcoHealth Alliance. EcoHealth Alliance received millions of dollars in grant money from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (that is, Anthony Fauci), the Defense Threat Reduction Agency (part of the US Department of Defense), and the United States Agency for International Development. NIH/NIAID contributed a few million dollars, and DTRA and USAID each contributed tens of millions of dollars towards this research. Altogether, it was over a hundred million dollars. EcoHealth Alliance subcontracted these grants to the Wuhan Institute of Virology, a lab in China with a very questionable safety record and poorly trained staff, so that they could conduct gain-of-function research, not in their fancy P4 lab, but in a level-2 lab where technicians wore nothing more sophisticated than perhaps a hairnet, latex gloves, and a surgical mask, instead of the bubble suits used when working with dangerous viruses. Chinese scientists in Wuhan reported being routinely bitten and urinated on by laboratory animals. Why anyone would outsource this dangerous and delicate work to the People’s Republic of China, a country infamous for industrial accidents and massive explosions that have claimed hundreds of lives, is completely beyond me, unless the aim was to start a pandemic on purpose. In November of 2019, three technicians at the Wuhan Institute of Virology developed symptoms consistent with a flu-like illness. Anthony Fauci, Peter Daszak, and Ralph Baric knew at once what had happened, because back channels exist between this laboratory and our scientists and officials. December 12th, 2019, Ralph Baric signed a Material Transfer Agreement (essentially, an NDA) to receive Coronavirus mRNA vaccine-related materials co-owned by Moderna and NIH. It wasn’t until a whole month later, on January 11th, 2020, that China allegedly sent us the sequence to what would become known as SARS-CoV-2. Moderna claims, rather absurdly, that they developed a working vaccine from this sequence in under 48 hours. Stephane Bancel, the current CEO of Moderna, was formerly the CEO of bioMerieux, a French multinational corporation specializing in medical diagnostic tech, founded by one Alain Merieux. Alain Merieux was one of the individuals who was instrumental in the construction of the Wuhan Institute of Virology’s P4 lab. The sequence given as the closest relative to SARS-CoV-2, RaTG13, is not a real virus. It is a forgery. It was made by entering a gene sequence by hand into a database, to create a cover story for the existence of SARS-CoV-2, which is very likely a gain-of-function chimera produced at the Wuhan Institute of Virology and was either leaked by accident or intentionally released. The animal reservoir of SARS-CoV-2 has never been found. This is not a conspiracy “theory”. It is an actual criminal conspiracy, in which people connected to the development of Moderna’s mRNA-1273 are directly connected to the Wuhan Institute of Virology and their gain-of-function research by very few degrees of separation, if any. The paper trail is well- established. The lab-leak theory has been suppressed because pulling that thread leads one to inevitably conclude that there is enough circumstantial evidence to link Moderna, the NIH, the WIV, and both the vaccine and the virus’s creation together. In a sane country, this would have immediately led to the world’s biggest RICO and mass murder case. Anthony Fauci, Peter Daszak, Ralph Baric, Shi Zhengli, and Stephane Bancel, and their accomplices, would have been indicted and prosecuted to the fullest extent of the law. Instead, billions of our tax dollars were awarded to the perpetrators. The FBI raided Allure Medical in Shelby Township north of Detroit for billing insurance for “fraudulent COVID-19 cures”. The treatment they were using? Intravenous Vitamin C. An antioxidant. Which, as described above, is an entirely valid treatment for COVID-19-induced sepsis, and indeed, is now part of the MATH+ protocol advanced by Dr. Paul E. Marik. The FDA banned ranitidine (Zantac) due to supposed NDMA (N-nitrosodimethylamine) contamination. Ranitidine is not only an H2 blocker used as antacid, but also has a powerful antioxidant effect, scavenging hydroxyl radicals. This gives it utility in treating COVID-19. The FDA also attempted to take N-acetylcysteine, a harmless amino acid supplement and antioxidant, off the shelves, compelling Amazon to remove it from their online storefront. This leaves us with a chilling question: did the FDA knowingly suppress antioxidants useful for treating COVID-19 sepsis as part of a criminal conspiracy against the American public? The establishment is cooperating with, and facilitating, the worst criminals in human history, and are actively suppressing non-vaccine treatments and therapies in order to compel us to inject these criminals’ products into our bodies. This is absolutely unacceptable. COVID-19 Vaccine Development and Links to Transhumanism: This section deals with some more speculative aspects of the pandemic and the medical and scientific establishment’s reaction to it, as well as the disturbing links between scientists involved in vaccine research and scientists whose work involved merging nanotechnology with living cells. On June 9th, 2020, Charles Lieber, a Harvard nanotechnology researcher with decades of experience, was indicted by the DOJ for fraud. Charles Lieber received millions of dollars in grant money from the US Department of Defense, specifically the military think tanks DARPA, AFOSR, and ONR, as well as NIH and MITRE. His specialty is the use of silicon nanowires in lieu of patch clamp electrodes to monitor and modulate intracellular activity, something he has been working on at Harvard for the past twenty years. He was claimed to have been working on silicon nanowire batteries in China, but none of his colleagues can recall him ever having worked on battery technology in his life; all of his research deals with bionanotechnology, or the blending of nanotech with living cells. The indictment was over his collaboration with the Wuhan University of Technology. He had double- dipped, against the terms of his DOD grants, and taken money from the PRC’s Thousand Talents plan, a program which the Chinese government uses to bribe Western scientists into sharing proprietary R&D information that can be exploited by the PLA for strategic advantage. Charles Lieber’s own papers describe the use of silicon nanowires for brain-computer interfaces, or “neural lace” technology. His papers describe how neurons can endocytose whole silicon nanowires or parts of them, monitoring and even modulating neuronal activity. Charles Lieber was a colleague of Robert Langer. Together, along with Daniel S. Kohane, they worked on a paper describing artificial tissue scaffolds that could be implanted in a human heart to monitor its activity remotely. Robert Langer, an MIT alumnus and expert in nanotech drug delivery, is one of the co-founders of Moderna. His net worth is now $5.1 billion USD thanks to Moderna’s mRNA-1273 vaccine sales. Both Charles Lieber and Robert Langer’s bibliographies describe, essentially, techniques for human enhancement, i.e. transhumanism. Klaus Schwab, the founder of the World Economic Forum and the architect behind the so-called “Great Reset”, has long spoken of the “blending of biology and machinery” in his books. Since these revelations, it has come to the attention of independent researchers that the COVID-19 vaccines may contain reduced graphene oxide nanoparticles. Japanese researchers have also found unexplained contaminants in COVID-19 vaccines. Graphene oxide is an anxiolytic. It has been shown to reduce the anxiety of laboratory mice when injected into their brains. Indeed, given SARS-CoV-2 Spike’s propensity to compromise the blood-brain barrier and increase its permeability, it is the perfect protein for preparing brain tissue for extravasation of nanoparticles from the bloodstream and into the brain. Graphene is also highly conductive and, in some circumstances, paramagnetic. In 2013, under the Obama administration, DARPA launched the BRAIN Initiative; BRAIN is an acronym for Brain Research Through Advancing Innovative Neurotechnologies®. This program involves the development of brain-computer interface technologies for the military, particularly non-invasive, injectable systems that cause minimal damage to brain tissue when removed. Supposedly, this technology would be used for healing wounded soldiers with traumatic brain injuries, the direct brain control of prosthetic limbs, and even new abilities such as controlling drones with one’s mind. Various methods have been proposed for achieving this, including optogenetics, magnetogenetics, ultrasound, implanted electrodes, and transcranial electromagnetic stimulation. In all instances, the goal is to obtain read or read-write capability over neurons, either by stimulating and probing them, or by rendering them especially sensitive to stimulation and probing. However, the notion of the widespread use of BCI technology, such as Elon Musk’s Neuralink device, raises many concerns over privacy and personal autonomy. Reading from neurons is problematic enough on its own. Wireless brain-computer interfaces may interact with current or future wireless GSM infrastructure, creating neurological data security concerns. A hacker or other malicious actor may compromise such networks to obtain people’s brain data, and then exploit it for nefarious purposes. However, a device capable of writing to human neurons, not just reading from them, presents another, even more serious set of ethical concerns. A BCI that is capable of altering the contents of one’s mind for innocuous purposes, such as projecting a heads-up display onto their brain’s visual center or sending audio into one’s auditory cortex, would also theoretically be capable of altering mood and personality, or perhaps even subjugating someone’s very will, rendering them utterly obedient to authority. This technology would be a tyrant’s wet dream. Imagine soldiers who would shoot their own countrymen without hesitation, or helpless serfs who are satisfied to live in literal dog kennels. BCIs could be used to unscrupulously alter perceptions of basic things such as emotions and values, changing people’s thresholds of satiety, happiness, anger, disgust, and so forth. This is not inconsequential. Someone’s entire regime of behaviors could be altered by a BCI, including such things as suppressing their appetite or desire for virtually anything on Maslow’s Hierarchy of Needs. Anything is possible when you have direct access to someone’s brain and its contents. Someone who is obese could be made to feel disgust at the sight of food. Someone who is involuntarily celibate could have their libido disabled so they don’t even desire sex to begin with. Someone who is racist could be forced to feel delight over cohabiting with people of other races. Someone who is violent could be forced to be meek and submissive. These things might sound good to you if you are a tyrant, but to normal people, the idea of personal autonomy being overridden to such a degree is appalling. For the wealthy, neural laces would be an unequaled boon, giving them the opportunity to enhance their intelligence with neuroprosthetics (i.e. an “exocortex”), and to deliver irresistible commands directly into the minds of their BCI-augmented servants, even physically or sexually abusive commands that they would normally refuse. If the vaccine is a method to surreptitiously introduce an injectable BCI into millions of people without their knowledge or consent, then what we are witnessing is the rise of a tyrannical regime unlike anything ever seen before on the face of this planet, one that fully intends to strip every man, woman, and child of our free will. Our flaws are what make us human. A utopia arrived at by removing people’s free will is not a utopia at all. It is a monomaniacal nightmare. Furthermore, the people who rule over us are Dark Triad types who cannot be trusted with such power. Imagine being beaten and sexually assaulted by a wealthy and powerful psychopath and being forced to smile and laugh over it because your neural lace gives you no choice but to obey your master. The Elites are forging ahead with this technology without giving people any room to question the social or ethical ramifications, or to establish regulatory frameworks that ensure that our personal agency and autonomy will not be overridden by these devices. They do this because they secretly dream of a future where they can treat you worse than an animal and you cannot even fight back. If this evil plan is allowed to continue, it will spell the end of humanity as we know it. Conclusions: The current pandemic was produced and perpetuated by the establishment, through the use of a virus engineered in a PLA-connected Chinese biowarfare laboratory, with the aid of American taxpayer dollars and French expertise. This research was conducted under the absolutely ridiculous euphemism of “gain-of-function” research, which is supposedly carried out in order to determine which viruses have the highest potential for zoonotic spillover and preemptively vaccinate or guard against them. Gain-of-function/gain-of-threat research, a.k.a. “Dual-Use Research of Concern”, or DURC, is bioweapon research by another, friendlier-sounding name, simply to avoid the taboo of calling it what it actually is. It has always been bioweapon research. The people who are conducting this research fully understand that they are taking wild pathogens that are not infectious in humans and making them more infectious, often taking grants from military think tanks encouraging them to do so. These virologists conducting this type of research are enemies of their fellow man, like pyromaniac firefighters. GOF research has never protected anyone from any pandemic. In fact, it has now started one, meaning its utility for preventing pandemics is actually negative. It should have been banned globally, and the lunatics performing it should have been put in straitjackets long ago. Either through a leak or an intentional release from the Wuhan Institute of Virology, a deadly SARS strain is now endemic across the globe, after the WHO and CDC and public officials first downplayed the risks, and then intentionally incited a panic and lockdowns that jeopardized people’s health and their livelihoods. This was then used by the utterly depraved and psychopathic aristocratic class who rule over us as an excuse to coerce people into accepting an injected poison which may be a depopulation agent, a mind control/pacification agent in the form of injectable “smart dust”, or both in one. They believe they can get away with this by weaponizing the social stigma of vaccine refusal. They are incorrect. Their motives are clear and obvious to anyone who has been paying attention. These megalomaniacs have raided the pension funds of the free world. Wall Street is insolvent and has had an ongoing liquidity crisis since the end of 2019. The aim now is to exert total, full-spectrum physical, mental, and financial control over humanity before we realize just how badly we’ve been extorted by these maniacs. The pandemic and its response served multiple purposes for the Elite: Concealing a depression brought on by the usurious plunder of our economies conducted by rentier-capitalists and absentee owners who produce absolutely nothing of any value to society whatsoever. Instead of us having a very predictable Occupy Wall Street Part II, the Elites and their stooges got to stand up on television and paint themselves as wise and all-powerful saviors instead of the marauding cabal of despicable land pirates that they are. Destroying small businesses and eroding the middle class. Transferring trillions of dollars of wealth from the American public and into the pockets of billionaires and special interests. Engaging in insider trading, buying stock in biotech companies and shorting brick-and-mortar businesses and travel companies, with the aim of collapsing face-to-face commerce and tourism and replacing it with e-commerce and servitization. Creating a casus belli for war with China, encouraging us to attack them, wasting American lives and treasure and driving us to the brink of nuclear armageddon. Establishing technological and biosecurity frameworks for population control and technocratic- socialist “smart cities” where everyone’s movements are despotically tracked, all in anticipation of widespread automation, joblessness, and food shortages, by using the false guise of a vaccine to compel cooperation. Any one of these things would constitute a vicious rape of Western society. Taken together, they beggar belief; they are a complete inversion of our most treasured values. What is the purpose of all of this? One can only speculate as to the perpetrators’ motives, however, we have some theories. The Elites are trying to pull up the ladder, erase upward mobility for large segments of the population, cull political opponents and other “undesirables”, and put the remainder of humanity on a tight leash, rationing our access to certain goods and services that they have deemed “high-impact”, such as automobile use, tourism, meat consumption, and so on. Naturally, they will continue to have their own luxuries, as part of a strict caste system akin to feudalism. Why are they doing this? Simple. The Elites are Neo-Malthusians and believe that we are overpopulated and that resource depletion will collapse civilization in a matter of a few short decades. They are not necessarily incorrect in this belief. We are overpopulated, and we are consuming too many resources. However, orchestrating such a gruesome and murderous power grab in response to a looming crisis demonstrates that they have nothing but the utmost contempt for their fellow man. To those who are participating in this disgusting farce without any understanding of what they are doing, we have one word for you. Stop. You are causing irreparable harm to your country and to your fellow citizens. To those who may be reading this warning and have full knowledge and understanding of what they are doing and how it will unjustly harm millions of innocent people, we have a few more words. Damn you to hell. You will not destroy America and the Free World, and you will not have your New World Order. We will make certain of that. *  *  * This PDF document contains 14 pages, followed by another 17 pages of references. For those, please visit the original PDF file at Covid19 – The Spartacus Letter. *  *  * We try to run the Automatic Earth on donations. Since ad revenue has collapsed, you are now not just a reader, but an integral part of the process that builds this site. Thank you for your support. Support the Automatic Earth in virustime. Donate with Paypal, Bitcoin and Patreon. Tyler Durden Mon, 09/27/2021 - 00:00.....»»

Category: dealsSource: nyt3 hr. 31 min. ago

A CIA station chief was recalled after claims he wasn"t taking victims of the mysterious "Havana Syndrome" seriously

The first case of the illness was reported by US officials stationed in Cuba in 2016. More than 130 cases have emerged worldwide since. The logo of the CIA. Saul Loeb/AFP via Getty Images The CIA recalled a top agent accused of doubting "Havana Syndrome," cases, per The Washington Post. The agent headed the CIA station in Vienna, which has reported several cases, The Post said. US intelligence agencies are working to identify the cause of the mysterious illness. See more stories on Insider's business page. The head of the CIA's station in Vienna, Austria, has been recalled over claims he doubted victims of the mysterious "Havana Syndrome," The Washington Post reported.The man, who has not been named, was said to be skeptical about the illness and insensitive to those who said they had experienced it, The Post said.The first case of what is now known as "Havana Syndrome" was reported by US officials stationed in Havana, Cuba, in 2016. Since then, more than 130 cases have emerged. More cases of the "Havana Syndrome" - which CIA officially calls "anomalous health incidents" - have been reported in Vienna than anywhere else bar Cuba.Symptoms include headaches, vertigo, hearing loss, and the appearance of buzzing or clicking sounds. Theories on the cause of the illness range from microwaves and ultrasound to parasites. Dozens of US diplomats, officials, and their families have been affected in the Austrian capital. Some children of US employees have also been affected there, The Post reported.In August, several offices at the US mission in Vienna shut down as a result of the illness, The Post said.The removal of the Vienna station chief shows the CIA is taking "Havana Syndrome" cases seriously.Earlier this month, the Department of Defense sent a memo to 2.9 million military service members and civilians asking them to report any symptoms that line up with the illness.On a trip to India this month, a person traveling with CIA Director Bill Burns experienced symptoms of the illness, CNN reported.Employees of the CIA told the network that the episode was perceived internally as a direct threat to Burns, and that Burns was furious when he found out.The Vienna recall follows the departure this month of Ambassador Pamela Spratlen, the top US official overseeing the State Department's response to the illness, after three months on the job.The department said Spratlen left because she had "reached the threshold of hours of labor" as a retiree. But NBC News reported that she left following criticism of her decision not to say if she believed an FBI study that said the "Havana Syndrome" could be a mental affectation.Read the original article on Business Insider.....»»

Category: topSource: businessinsiderSep 24th, 2021

Mike Lindell should accept he"s wrong about voter fraud, Alabama Republican tells Insider. If not, "most people would say, "You"re an idiot.""

Alabama Secretary of State John Merrill claims he only met with MyPillow conspiracy theorist Mike Lindell to show him the 2020 election was fair. Founder and CEO of My Pillow, conservative political activist and conspiracy theorist Mike Lindell (C) listens to former U.S. President Donald Trump addresses supporters during a "Save America" rally at York Family Farms on August 21, 2021 in Cullman, Alabama. Chip Somodevilla/Getty Images Alabama Secretary of State John Merrill spoke to Insider about his meeting with Mike Lindell. Lindell has claimed, without evidence, that 100,000 votes were "flipped" in Alabama. The two met at a Trump rally in August, Merrill said. See more stories on Insider's business page. If Mike Lindell is a "reasonable, thinking person," there's still a chance he could be talked down from his claim that there was systemic voter fraud even in a state as deep-red as Alabama. And if he's not? Like Joe McCarthy, the senator who spent the 1950s on a witch hunt for communists, the pillow magnate could end up being seen as "just perpetuating a myth he had created for self-promotion."That's according to John Merrill, a former chairman of the Alabama Republican Party who since 2015 has served as the state's top elections official. He spoke to Insider after meeting with Lindell - and after the CEO of MyPillow, born again as a crusader against the results of the 2020 election, alleged in a video on his website that some 100,000 ballots were "flipped" in a state that former President Donald Trump carried with 62% of the vote.On September 17, Alabama's Secretary of State met with Lindell to discuss what his office described as "several topics that were of concern to Mr. Lindell and other citizens." That meeting took place after the two connected at a Trump rally in August, and after Lindell - who has prophesied that the ex-president will be reinstated before the end of the year - paid $30,000 to obtain a copy of the state's voter list."Mr. Lindell was claiming that Alabama had votes changed more than five or six weeks ago, which is what started the entire conversation," Merrill said. There, for three-and-a-half hours, Lindell and his associates shared what they presented as evidence that votes were changed, from Trump to President Joe Biden, on the day of the election. "He showed us a report about when the votes were 'flipped,'" he said. But the times when the alleged incidents occurred didn't make any sense. "I'm like, 'How did that happen when the polls were not even open?' And it was like that on a number of different things. They didn't really have a response to that."They didn't really have a response to evidence that the machines could not have been "hacked," either, as Lindell has claimed they were (state and national cybersecurity officials, including members of the Trump administration, described the 2020 election "as the most secure in American history"). In a video posted to his website after the meeting, Lindell praised Merrill's leadership and acknowledged his statement that voting machines in Alabama are never connected to the internet - that they don't even have modems. But he was undeterred."We're going to find that hole," Lindell said. "I know we'll find something in the machines."This was of course a predictable outcome - and a good reason, critics say, not to have given a notorious crank the time of day. Alabama Secretary of State John Merrill shared a story on Wednesday that identified Mike Lindell as a "conspiracy theorist." Screenshot/Twitter Legitimizing or challenging a conspiracy theorist?"It's pathetic and so obvious that Merrill is sucking up to Trump," Wade F. Perry, executive director of the Alabama Democratic Party, told Insider. "It's all political theater," he said, "and it's stupid."Merrill insists he has not come to any conclusion about Lindell himself, and would indeed meet with him again. This, despite sharing a news story on his personal Twitter account that identified him as a "conspiracy theorist." Like it or not, Merrill argued, "he does have a pulpit." It's important to rebut popular claims, even - perhaps, especially - if they come from a false prophet. And the man himself could come around, right?"I know he's a multimillionaire and he didn't get to become a multimillionaire by being crazy and doing stupid things all the time," Merrill argued."A logical, reasonable-thinking person is going to say, 'I must be wrong in what I'm looking at.' And if you can't be moved from that position, then you are not very intelligent," Merrill said. "And most people would say, 'You're an idiot.'"Time will certainly tell. In the 1950s, a Republican lawmaker, Margaret Chase Smith, spoke publicly against the "irresponsible sensationalism" of one Joe McCarthy, another member of the GOP."Then he went the way of the buffalo, that's what happened to him," Merrill said. "And if this happens with Mr. Lindell, then so be it. It'll be a sad day for him, but it'll be a great day for the country."From Maricopa County, Arizona, to Philadelphia, Pennsylvania, quite a few Republicans - the ones who actually administer elections - who have been willing to question the decency of others within their party pushing the lie that the 2020 election was decided not by American voters but by Chinese communists. The problem is that the head of that party, the man who lost in November, is the leading purveyor of these falsehoods. So long as Donald Trump has an unchallenged grip over the GOP, including support from many of these same state and local officials; keeps doubling down on outlandish excuses for his loss; and continues directing his followers to attack those who challenge his claims, the likes of Mike Lindell will continue to have a congregation.Have a news tip? Email this reporter: cdavis@insider.comRead the original article on Business Insider.....»»

Category: topSource: businessinsiderSep 23rd, 2021

Noom users say they feel misled by the diet app

These are Insider's biggest healthcare stories for September 23. Hello,Welcome to Insider Healthcare. I'm Leah Rosenbaum, a new healthcare editor at Insider who will be helping Lydia with this newsletter for the next few months. Today in healthcare news:Weight-loss app Noom calls itself anti-diet, but users say they it relies on calorie restriction;Former Accolade executive Dr. Alan Spiro is joining at-home care startup Laguna Health;Polls show that Americans are just fine with COVID-19 vaccine mandates. If you're new to this newsletter, sign up here. Comments, tips? Email me at lrosenbaum@insider.com or tweet @leah_rosenbaum. As Lydia likes to say, let's get to it...First - some breaking news from last night. The FDA on Wednesday evening authorized boosters of Pfizer and BioNTech's COVID-19 vaccine for people 65 and up and people at higher risk.That includes people between 18-64 who are at higher risk of getting a severe COVID-19 case, and people at higher risk based on where they work or where they live. Boosters are only available to people who were initially vaccinated with the Pfizer-BioNTech shot.Read the full story>> Crystal Cox/Business Insider Noom markets itself as an anti-diet lifestyle app. Users say they find themselves counting calories, receiving canned advice from burned-out coaches, and taking on expensive subscriptions.Noom is an industry leader in weight-loss apps with millions of dollars in venture-capital funding.The company pitches itself as offering personalized weight-loss support using psychological methods.Users and former employees say it relies on calorie restriction and coaches are burned out. Get the full story>> Laguna Health's app helps patients recover at home. Laguna Health A longtime Accolade executive is setting his sights on at-home care as the next big opportunity for upending how care is delivered in the USDr. Alan Spiro, a longtime Accolade executive, is joining Laguna Health as its chief medical officer and president.At-home care has been an area of growth for digital health during the COVID-induced funding boom.The rapid adoption of telehealth helped startups offering in-home care, Laguna CEO Yoni Shtein said.Check it out now>> A band-aid is placed on the arm of a 12 year old child after they received a first dose of the Pfizer Covid-19 vaccine after it was approved for use by the FDA in children 12 and over at a Los Angeles County mobile vaccination clinic on May 14, 2021 in Los Angeles, California. Patrick Fallon/AFP/Getty Images Poll after poll shows the same thing: Americans are cool with vaccine mandatesThree recent polls show that a majority of Americans support vaccine mandates. The popularity of vaccine requirements has risen as the Delta variant surged.Hardline opposition to getting vaccinated has fallen to a new low. Read more here>> More stories we're reading:Some doctors are spreading COVID-19 misinformation. Will they be held accountable? (Kaiser Health News)China's biotech industry has quietly surged to a $180 billion behemoth. Here's how it's reshaping biotech as we know it, from M&A to drug pricing (Insider)A new federal office plans to look at climate change through a public-health lens (The Wall Street Journal)Tennessee says vaccinated people should be last in line for antibody treatments to save them for the unvaccinated (Insider)-LeahRead the original article on Business Insider.....»»

Category: topSource: businessinsiderSep 23rd, 2021

NASDAQ Hits New Record as Stocks Overcome Weak Jobs Data

NASDAQ Hits New Record as Stocks Overcome Weak Jobs Data A disappointing jobless claims report dragged stocks lower in the morning, but good old technology helped the market recover and even log another record close. Let’s just get the unpleasantries out of the way. There were over 1.1 million jobless claims last week, which was more than expected. Even worse though, it comes just a week after this report dipped under 1 million for the first time in 20 straight weeks, making it even more disheartening. And we’re just a day removed from a less-than-enthusiastic read on the economy from the Fed, which stated that this pandemic could “weigh heavily” on prospects for the near-term and possibly medium-term. Maybe such news will foster some urgency in Congress to get a coronavirus relief packaged passed. But don’t hold your breath. Nevertheless, the market persevered with a lot of help from tech. The FAANGs all gained more than 2% on Wednesday save Amazon (AMZN) with a 1.13% advance. Microsoft (MSFT) was over 2% too. As a result, the NASDAQ jumped 1.06% (or around 118 points) to a new record of 11,264.95. This marks the third milestone for the index this week. The S&P was up 0.32% to 3385.51, while the Dow broke a three-day losing skid by rising 0.17% (or nearly 47 points) to 27,739.73. The NASDAQ and S&P are both higher for the week heading into Friday’s session. The former index is actually up more than 2% so far on a strong week for technology. The Dow is down by less than 1%. It’s shaping up to be the opposite of last week when the Dow jumped 1.8% while the NASDAQ fought to stay positive. Today's Portfolio Highlights: Surprise Trader: Natural and organic foods company Hain Celestial (HAIN) will be going for a fourth straight positive surprise on Tuesday, August 25th before the bell. With a positive Earnings ESP of 2.94%, the company has a good chance of succeeding. The Zacks Consensus Estimate for this quarter calls for earnings growth of more than 28%, while next quarter’s is as high as 112%. Dave added HAIN on Thursday with a 12.5% allocation, while also selling JELDWEN (JELD) for an 8.5% return in less than a month. Read the full write-up for more.  Technology Innovators: The portfolio swapped out chip names on Thursday as Brian does a little fine-tuning. The editor sold Semtech (SMTC) for a nearly 21% return in a little over two months, and replaced it by adding FormFactor (FORM). The new buy is an OEM of automated wafer probe cards that are used in the back-end portion of the semiconductor manufacturing process. FORM has beaten the Zacks Consensus Estimate in each of the past four quarters with an average surprise of 28%. Rising earnings estimates have made it a Zacks Rank #1 (Strong Buy). Increasing margins should lead to higher EPS and a bigger multiple, which Brian believes will send FORM into the mid $30s. The service also sold the underperforming Simulations Plus (SLP) position today. Read the full write-up for more specifics on today’s moves. By the way, this portfolio had the best performer of the day as Tesla (TSLA) rose 6.56%.  Insider Trader: Shares of New Relic (NEWR) sold off after its recent quarterly report, but this analytics and infrastructure software company is in a transition phase. It’s reducing products from 11 all the way down to 3 and introduced a new free tier. Apparently, the President & COO feels pretty good about these moves, because he bought 9,000 shares yesterday, which comes to about $510,000. Tracey sees this as a “confidence buy” and decided to add this name with the remaining 10% in cash. Therefore, this portfolio is now fully invested. The complete commentary has more specifics on this new addition. All the Best, Jim Giaquinto Recommendations from Zacks' Private Portfolios: Believe it or not, this article is not available on the Zacks.com website. The commentary is a partial overview of the daily activity from Zacks' private recommendation services. If you would like to follow our Buy and Sell signals in real time, we've made a special arrangement for readers of this website. Starting today you can see all the recommendations from all of Zacks' portfolios absolutely free for 7 days. Our services cover everything from value stocks and momentum trades to insider buying and positive earnings surprises (which we've predicted with an astonishing 80%+ accuracy). Click here to "test drive" Zacks Ultimate for FREE >>  Zacks Investment Research.....»»

Category: topSource: zacksSep 21st, 2021

S&P Joins NASDAQ at New Highs After Infrastructure Agreement

S&P Joins NASDAQ at New Highs After Infrastructure Agreement A possible infrastructure deal got the major indices moving higher again on Thursday, helping the S&P to finally reach a new record. Meanwhile, stocks seem poised for solid weekly totals heading into Friday’s session. Let’s not get too excited about this infrastructure thing just yet. We know how Washington can be. Basically, the White House and a bipartisan group of senators have agreed on something. We still don’t know all the details or how it will be funded. We don’t even know if the plan will pass. However, it’s progress… and that was good enough for the market today. The NASDAQ just finished its third straight day in record territory, jumping 0.69% (or about 98 points) to a new high of 14,369.71. And the S&P is back to making history as well. The index rose 0.58% to 4266.49, which marks its first closing record high since Monday, June 14. The Dow jumped 0.95% (or around 322 points) to 34,196.82. All of these indices are up more than 2% for the week heading into Friday’s session, which means it has a good chance to recover from last week’s losses stemming from the Fed announcement. The jobless claims report was very similar to last time. The print showed 411,000 claims, which was only modestly better than the previous week’s upwardly-revised 418K. However, it missed expectations of around 380K. Other bits of economic data on Thursday included durable goods, which jumped 2.3% in May for a nice rebound from April’s plunge. However, it also missed expectations. But preliminary GDP was unrevised and right on target at 6.4%. “This all backs the idea that the economy isn’t too hot yet and the Fed can wait to taper and raise rates. This Goldilocks environment pleases the bulls,” said Jeremy Mullin in Counterstrike. And we’re not done with the data this week. Tomorrow comes the  personal consumptions expenditures report, which soared by more than 3% last time. However, the market took the print in stride as they feared much worse. The report is expected to show another sharp increase on Friday, so it’ll be interesting to see how investors react this time. Today's Portfolio Highlights:   Blockchain Innovators: It probably wouldn’t take many guesses to figure out what Benefitfocus (BNFT) does. It's a technology platform that simplifies benefits administration for employers, health plans and brokers. The company recently announced major expansions to its platform through artificial intelligence. So BNFT has been using blockchain for a while and looks to employ even more of it in the future. This Zacks Rank #2 (Buy) beat the Zacks Consensus Estimate in each of the last three quarters, and is expected to grow earnings more than 34% this year and over 46% next year. Dave added BNFT on Thursday, while also selling Net 1 UEPS Tech (UEPS) after several months of negative action. The complete commentary has more on today’s moves. Commodity Innovators: The portfolio swapped a couple energy positions on Thursday. First of all, Jeremy sold Devon Energy (DVN) after its Zacks Rank fell. Shares have bounced back a bit from a selloff, so this was a good time to sell the name for a 33.4% profit in less than three months. The new addition is Schlumberger (SLB), a Zacks Rank #1 (Strong Buy) oil services leader. The company beat the Zacks Consensus Estimate by 10% back in April and is benefiting from the rising price of oil. In fact, if oil gets up to $100, the editor thinks that SLB will make new highs rather quickly. Read the complete commentary for more. Options Trader: For the third time this year, Kevin is pulling profits and repositioning his options in Nasdaq (NDAQ). The editor sold to close the September 165.00 Call for a 137% return and bought to open a September 180.00 Call. As subscribers know, the editor calls this a “free trade” since the original principal is now safe with still tons of potential for profit moving forward. But that’s not all. Kevin also bought to open a December 540.00 Call in Thermo Fisher Scientific (TMO) and bought to open an October 105.00 Call in Floor & Décor Holdings (FND). TMO looks like it may finally be ready to breakout of a large bullish flagging pattern, while FND is a Zacks Rank #1 (Strong Buy) with projected sales and EPS growth of more than 34% and 54%, respectively. Read the full write-up for more specifics on these moves. TAZR Trader: Don’t count C3.ai (AI) out! This software company was a high-flying IPO last year... and then it “crashed and burned like Icarus”. However, CEO Thomas Siebel knows how to build an innovative tech company and has designs to make this name a global leader in enterprise artificial intelligence software for accelerating the digital transformation. It’s fiscal fourth quarter results from earlier this month shows it’s on the right track. Revenue rose 26% year over year, while subscription revenue advanced 17%. AI is also very attractively priced for a company with sales growth expectations of 33.5% this fiscal year and another 32.5% for next. The partnership with data cloud company Snowflake is a nice move for the future as well. Read the full write-up to learn a lot more about AI, including Siebel’s ambitions moving forward and the “recalibration’ of analysts. In other news, this portfolio had two of the best performers among all ZU names on Thursday as The Trade Desk (TTD) rose 16% and Magnite (MGNI) advanced 8.2%. Technology Innovators: Shares of NVIDIA (NVDA) have been on a solid run... and Brian doesn’t think it’s over. The portfolio needs some big-cap exposure, so he added this Zacks Rank #2 (Buy) graphics chip pioneer on Thursday. However, the editor sees NVDA as a broad-based computing powerhouse that goes far beyond chips. The company has beaten the Zacks Consensus Estimate in each of the last four quarters with an average surprise of 12%, while the topline is expected to grow 48% this year and 10% in fiscal 2023. There’s a 4 for 1 stock split coming up in about a month. Meanwhile, the service also sold Cornerstone OnDemand (CSOD) for a more than 16% return in a little over six months and Vishay Intertechnology (VSH) for a loss. Read the full write-up for more on today’s action. In addition, this portfolio had a top performer today as Criteo S.A. (CRTO) advanced 12.3%. Until Tomorrow, Jim Giaquinto Recommendations from Zacks' Private Portfolios: Believe it or not, this article is not available on the Zacks.com website. The commentary is a partial overview of the daily activity from Zacks' private recommendation services. If you would like to follow our Buy and Sell signals in real time, we've made a special arrangement for readers of this website. Starting today you can see all the recommendations from all of Zacks' portfolios absolutely free for 7 days. Our services cover everything from value stocks and momentum trades to insider buying and positive earnings surprises (which we've predicted with an astonishing 80%+ accuracy). Click here to "test drive" Zacks Ultimate for FREE >>  Zacks Investment Research.....»»

Category: topSource: zacksSep 21st, 2021

Strong Jobs Report Sends All Major Indices to New Highs

Strong Jobs Report Sends All Major Indices to New Highs A strong jobs report gave investors a fantastic start to the long Fourth of July weekend, as each of the major indices finished Friday’s session at new closing highs. And yes, that also includes the Dow! We’ve been thinking about the Government Employment situation report all week… and it was well worth the wait. The economy added 850,000 jobs last month, which jumped past expectations in the low 700Ks and was more than 200K better than the previous month. Even though the print blew past Wall Street forecasts (unlike the May number), a lot of people are still calling this a ‘goldilocks’ report. It obviously shows an economy that’s rapidly getting back on its feet after an unprecedented interruption, but market watchers apparently feel that it’s not enough to force the Fed to accelerate a rate hike. The end result on Friday was the S&P reporting its seventh straight record close by gaining 0.75% to 4352.34. The NASDAQ is also back at a new high with a rise of 0.81% (or nearly 117 points) to 14,639.33. That’s the tech-heavy index’s first milestone since this past Tuesday. The Dow hadn’t seen a closing high since all the way back on May 7… until today that is. The index jumped 0.44% (or about 152 points) to a new record at 34,786.35. For the week, the NASDAQ led the way with a 1.9% advance as tech remains the pride of the market. The S&P is really close with a 1.7% advance after setting records for seven straight sessions, while the Dow participated with a 1% advance over the five days. Today’s report certainly attracted the lion’s share of attention this week, but we should remember that it’s actually the third positive jobs report in as many days. The ADP employment report on Wednesday easily beat expectations by adding 692K jobs in June, while the jobless claims report yesterday slipped back below 400K and surpassed expectations at 364K. Add some other positive economic data, a strong earnings season (with a new one about to begin), a rapid vaccine rollout and a Fed that’s still being super supportive amid a ‘transitory’ rise in inflation; and its no wonder that the first half totals were so epic with hope for more in the second half. Before we go celebrate Independence Day, let’s go over those first half results again... because they deserve to be repeated! The S&P soared 14.4%, the Dow jumped 12.7% and the NASDAQ rose 12.5%. After such amazing performances, the editors are now wondering when the pullback will come. And they’re actually pretty excited because it gives them a chance to buy at more attractive prices. But let’s think about that next week and enjoy our nation’s birthday… Today's Portfolio Highlights:    TAZR Trader: Before the Fourth of July weekend begins, Kevin has a couple of buys for the portfolio, First of all, he picked up Chinese e-commerce giant Alibaba (BABA), which is down today after China proposes rules to punish illegal e-commerce pricing. The editor calls this “a minor slap on the wrist for BABA”, which the company will undoubtedly obey to stay out of trouble. Therefore, its an opportunity. The service also added Penn National Gaming (PENN), a $12 billion gaming enterprise that’s seeing sales snap back as the pandemic loses its grip. The company pre-announced strong preliminary Q2 results late last month, which bodes well for the report coming in August. Kevin added each with 5% allocations. Read the full write-up for more on these buys, including a look at what the analysts are saying. Headline Trader: "Large-cap equities got a euphoric push into the long Independence Day weekend. This morning's robust June employment report exceeded expectations while wage growth remained muted, driving a fresh wave of bullish sentiment into equities and bonds alike. "We had a trifecta of record closes from all three of the large-cap indexes and marked the S&P 500?s 7th consecutive all-time high (the longest streak since last August). All the momentum is to the upside, but I am becoming increasingly nervous about the overbought territory that both the S&P 500 and Nasdaq 100 closed at today. "My outlook remains bullish for the 2nd half of 2021, but a market pullback may be necessary. As I have said in prior commentaries, there is a record level of sideline cash ($5.5 trillion in the money markets) just waiting to buy the dip." -- Dan Laboe Counterstrike: "Goldilocks and the dead bears. Are there any shorts left? "The S&P hit a record high for the 7th day in a row. This is the first time that happened since 1997. "We continue to be in an astonishing bull market, but the opportunity feels limited at these heights. Let’s take it slow into earnings and look to manage the portfolio and raise some cash." -- Jeremy Mullin Have a Happy 4th of July! Jim Giaquinto Recommendations from Zacks' Private Portfolios: Believe it or not, this article is not available on the Zacks.com website. The commentary is a partial overview of the daily activity from Zacks' private recommendation services. If you would like to follow our Buy and Sell signals in real time, we've made a special arrangement for readers of this website. Starting today you can see all the recommendations from all of Zacks' portfolios absolutely free for 7 days. Our services cover everything from value stocks and momentum trades to insider buying and positive earnings surprises (which we've predicted with an astonishing 80%+ accuracy). Click here to "test drive" Zacks Ultimate for FREE >>  Zacks Investment Research.....»»

Category: topSource: zacksSep 21st, 2021

A handwritten note on Ritz-Carlton paper shows Giuliani associate Lev Parnas spelling out his top goal for Ukraine"s president: Announce a criminal probe into Joe Biden

Mark Lennihan/AP; House Intelligence Committee An associate of President Donald Trump's personal lawyer Rudy Giuliani spelled out in a handwritten note his key objective for Ukraine President Volodymyr Zele.....»»

Category: topSource: businessinsiderJan 15th, 2020

Trump calls Democrats" impeachment inquiry a "witch hunt"

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchSep 25th, 2019

Market Extra: Trump calls Pelosi’s impeachment move ‘witch hunt garbage’ and ‘presidential harassment’

President Donald Trump on Tuesday afternoon goes on Twitter tirade after House Speaker Nancy Pelosi announced a formal impeachment inquiry......»»

Category: topSource: marketwatchSep 24th, 2019

Trump"s former White House lawyer says Robert Mueller is an "American hero" and says his report isn"t a "witch hunt"

REUTERS/Jonathan Ernst Ty Cobb, who represented the White House in Robert Mueller's Russia investigation, said the investigation is legitimate. The view is at odds with Trump himself, who calls it a "witch hunt." Cobb said t.....»»

Category: topSource: businessinsiderMar 22nd, 2019

What Is Attorney-Client Privilege? Trump Tweets It"s Dead and Attacks After Lawyer"s Office Raided

The president again called the special counsel's probe a "witch hunt.".....»»

Category: topSource: newsweekApr 10th, 2018

FBI raids Cohen; Trump brands Mueller"s probe an "attack on country"

Trump called the probe a "witch hunt," suggesting it was a distraction from serious issues, like the consideration of a military response to Syria's apparent use of a chemical weapon on civilians over.....»»

Category: topSource: business-standardApr 10th, 2018

Russia denounces Microsoft"s hacking claims as "witch-hunt," Reuters says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 21st, 2018

A new poll shows Trump"s disapproval rating just hit a new high. And his attacks on the Mueller probe could be backfiring.

Markets Insider A new ABC News/Washington Post poll shows 60% disapproval for President Donald Trum, and indicates his efforts to.....»»

Category: topSource: businessinsiderAug 31st, 2018